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Targeted drug delivery to the brain is difficult to achieve using conventional 
techniques, largely due to the blood-brain barrier’s (BBB) impediment to drug diffusion 
into the brain parenchyma.  In response, development of convection-enhanced delivery 
(CED) offers the ability to circumvent the BBB and target specific areas of the brain.  
Predictability of infusate movement in pathological brain states during CED will 
maximize the effectiveness of this treatment, and therefore modeling of infusate 
movement must be characterized.  Previous work from our lab effectively modeled CED 
in rats using the middle carotid artery occlusion model of cytotoxic edema.  However, 
previous models examined for vasogenic edema study did not show pure vasogenic 
edema.  The purpose of this study was to develop a model of pure vasogenic edema in the 
rat brain.  In this study, we show that stereotactic 9 µL infusion of 1.0 mM DCA over 45 
x 
 
 
minutes into the rat corpus callosum reproducibly creates pure vasogenic edema, as 
observed in the peritumoral white matter surrounding gliomas. 
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Chapter 1 
Introduction 
 
The Blood-Brain Barrier 
Neuroscience literature describes the blood-brain barrier (BBB) as both a 
structural and functional impediment to the movement of molecules from blood vessels 
into the brain parenchyma.  Paul Ehrlich showed the first evidence of the BBB when he 
demonstrated that intravenously-administered dyes stained many tissues except brain in 
the late 1800s.  Further experiments by his student, Edwin Goldman, showed that the 
dyes themselves had the ability to stain brain parenchyma when exposed to the brain 
through non-intravenous methods (Wells and Bonetta 2005).  Modern experimental 
techniques have since elucidated the complex cellular and molecular structures that 
comprise this barrier between blood and the brain (Huber et al. 2001), which is 
particularly limiting for high molecular weight (MW) and polar molecules (Bobo et al. 
1994). 
Histologically, the BBB consists of vascular endothelial cells connected by tight 
junctions and adherens junctions.  Pericytes overlay the endothelial cells and are 
considered part of the BBB because they participate in its function and share a common 
basement membrane with the endothelial cells (Ueno 2007).  Figure 1-1 provides an  
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Figure 1-1.  Illustration of the BBB and perivascular astrocytic foot processes.  Figure 
modified from Uneo (2007).  
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illustration of the BBB.  Astrocytic foot processes ensheath this structure and participate 
in its maintenance (Neuwelt 2004).  In fact, the CNS microenvironment is necessary for 
formation and maintenance of tight junctions by endothelial cells (Stewart and Wiley 
1981; Argaw et al. 2006).  Still, endothelial cells contribute to the metabolic requirement 
necessary for BBB function, and mitochondria comprise a large intracellularpresence in 
the endothelial cell ultrastructure (Ueno 2007). 
Tight junctions between the endothelial cells limit paracellular permeability of 
molecules with a MW larger than 200-400 Da between the blood vessel lumen and brain 
parenchyma, while other mechanisms of transport across the endothelium play minor 
roles (Neuwelt 2004). The network of tight junctions between endothelial cells is also 
referred to as the zonula occludens (Wang and Margolis 2007).  The structure of tight 
junctions consists of integral, transmembrane proteins that attach cytoplasmic accessory 
proteins on the intracellular face.  Claudins, occludins and junction adhesion molecules 
all comprise the integral membrane component of tight junctions (Huber et al. 2001).  
Adherens junctions also consist of transmembrane proteins, namely members of the 
cadherin family.  Cytoplasmic accessory proteins attach tight junctions and adherens 
junctions to the actin cytoskeleton of the endothelial cell.  ZO-1, ZO-2, ZO-3, cingulin, 
and additional proteins attach tight junctions, while p120 and catenins attach adherens 
junctions (Doolittle et al. 2005; Ueno 2007). 
As suggested above, the responsibility of BBB maintenance lies with astrocytes, 
endothelial cells and pericytes (Neuwelt 2004; Ueno 2007).  Astrocytic interaction with 
the endothelium is necessary for proper development and maintenance of the BBB 
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(Laterra et al. 1990), and astrocytes also maintain a suitable CNS microenvironment for 
the cells and structures involved.  In pathological brain states such as neuro-
inflammation, factors secreted by microglia and macrophages (such as Il-1β and 
histamine) lead to reactive astrogliosis and BBB disruption by interactions with the 
astrocytes and endothelium (Argaw et al. 2006). 
Under normal conditions, protein kinase C (PKC) in the endothelial cell asserts 
several important functions in tight junction regulation (Huber et al. 2001).  One such 
function is the maintenance of appropriate intracellular calcium levels, which is necessary 
for proper cadherin function and ZO-1 migration within the cytoplasm.  In addition, 
phosphorylation activity by PKC permits ZO-1 migration and proper sorting of tight 
junction proteins.  PKC also regulates intracellular adhesion molecule 1 (ICAM-1) 
transcription induced by tumor necrosis factor α (TNFα). 
Although proper BBB function is necessary for a normal brain environment 
(Neuwelt 2004), it provides a major obstacle in conventional drug delivery to CNS 
pathologies such as tumors and neurodegenerative disorders (Groothuis 2000).  As stated 
above, high MW and polar molecules do not readily pass the BBB, and therapeutic agents 
often have these characteristics (Bobo et al. 1994).  However, novel treatments to 
circumvent the BBB are being developed such as implantable polymers and convection-
enhanced delivery (CED) of drugs (Groothuis 2000; Haroun and Brem 2000).  The 
overlying goal of our lab is to optimize CED in pathological brain states, which will 
permit appropriate doses of therapeutic agents to reach the desired area. 
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Convection-Enhanced Delivery 
Delivery of medication into the brain has proven a major challenge to clinicians, 
and scientists continue to search for optimal ways of appropriately delivering drugs to 
specific targets.  Largely due to the BBB, medication from the bloodstream diffuses 
poorly into the brain parenchyma, especially with increasing molecular weight (Broaddus 
et al. 2001).  In 1977, Vick et al. (Vick et al. 1977; Groothuis et al. 2000) stated that the 
BBB did not provide a major obstacle to chemotherapeutic delivery and predicted that 
research on factors other than the BBB, such as dosage and route of delivery, would 
improve drug delivery.  Although supported by some, the large majority of literature 
supports the idea that the BBB provides a major obstacle to drug delivery (Groothuis 
2000).   
Common methods of drug delivery rely on simple diffusion of the drug to the 
target tissue.  The ability of a substance to diffuse relies on the properties of both the drug 
and the target tissue environment.  Several properties in particular hold great importance 
for brain such as MW, polarity, and the BBB (Bobo et al. 1994).  For example, diffusivity 
into normal brain rapidly decreases with increasing MW (Groothuis et al. 1999).  
Similarly, diffusion of high MW compounds into brain tumor tissue occurs slowly.  
Novel therapeutics (e.g. polypeptides, proteins or nucleic acids) tend to have high MW, 
and therefore simple diffusion to pathologic brain states from the vasculature is 
inadequate.  Given orally or intravascularly, the diffusion of compounds into the normal 
brain is much lower than into other target tissues, and the body acts as a large sink for 
most of the drug.  This sink effect also reduces the ability of the physician to deliver high 
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doses of a drug to a localized target.  Even for compounds with the capability to cross the 
BBB, any associated toxicity may affect other regions of the body and not localize to the 
brain (Haroun and Brem 2000). 
Infusion of drugs into the brain’s ventricular system does allow the surgeon to 
bypass the blood-cerebrospinal fluid (CSF) barrier, but has also proven unsuccessful due 
to the requirement that the compound diffuse from CSF into the brain parenchyma.  Even 
with compounds that would be expected to diffuse readily, diffusion alone cannot 
adequately deliver medication to the brain (Zovickian et al. 1987).  The amount of drug 
found in brain following intraventricular delivery is high at the ventricular border and 
sharply decreases with increasing distance from the ventricular wall (Blasberg et al. 
1975; Patlak and Fenstermacher 1975; Groothuis and Levy 1997).  Intraventricular drug 
delivery is thus suitable for pathologies in the subarachnoid space such as carcinomatous 
meningitis (Brown et al. 1996) but not for intraparenchymal delivery (Groothuis 2000).  
Localization of drugs to the target area allows for higher dosing and the potential 
to leave healthy tissue unharmed.  One approach uses degradable wafers containing the 
drug for direct intraparenchymal implantation.  MGI Pharma markets 3.85% BCNU-
impregnated polymer wafers that are implanted on the margins of the resection cavity 
after removing primary brain tumors.  This therapeutic strategy has undergone phase III 
clinical trials and has been demonstrated to improve mean survival time to 31 weeks 
compared to 23 weeks for placebo wafers (Bota et al. 2007).  Although this improvement 
is modest, it still shows the value and promise of local drug delivery as opposed to 
systemic delivery. 
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Utilizing the immune system provides another avenue for localization of drugs to 
the pathological area.  Even when given systemically, immunotherapeutics are intended 
to specifically target a tumor due to their ability to enhance the natural immune response 
a body creates in response to the tumor.  Cancer cells often show resistance to the 
immune response, also called immune evasion (Melero et al. 2007) and in vivo use of 
certain cytokines such as IL-2, 4, and 12 is currently under study to enhance the efficacy 
of the natural immune response.  Preliminary results, though, have shown significant 
systemic toxicity for IL-2 in early clinical trials (Haroun and Brem 2000). 
Although the above techniques address the problem of localization, diffusion is 
still the final common pathway for drugs to distribute throughout the target tissue and no 
technique has yielded impressive results.  As mentioned above, diffusion is only effective 
within very short (millimeter) distances, the concentration of the drug declines 
dramatically with increasing distance from its source, and tissue clearance can rapidly 
deplete the drug before it can diffuse over a long distance.  In addition, the large MWs 
characteristic of many therapeutics exacerbates the shortcomings of diffusion-based 
techniques.  In response to the issue of diffusion, researchers at the NIH began to 
optimize convection-enhanced delivery (CED), which creates a positive pressure gradient 
driving the bulk flow of infusate fluid (Bobo et al. 1994). 
Bobo et al. (1994) infused increasing volumes of 
111
In –labeled transferrin (111In-
Tf) and [
14
C]sucrose into the corona radiata of cats over time as representative high and 
low MW compounds.  In their paper the authors describe the convection pressure in 
relation to the flow rate for infusion and the positive linear relationship between volume 
9 
 
 
of infusate (Vi) and volume of distribution (Vd) of the infusate attributable to convection.  
Optimization of CED has since been a major focus to ensure predictable and effective 
drug delivery with minimal side effects for the patient.  Infusion covering an area of even 
a few centimeters takes numerous hours to complete, which places tremendous strains on 
the patient (Morrison et al. 1994).  Therefore, development of proper technology and 
determination of adequate dosing, volume, and flow rate have undergone much 
investigation (Groothuis 2000). 
The initial low flow rate is critical to prevent fluid backflow up the needle tract, 
and small incremental increases in the flow rate can be made during longer infusions 
(Bobo et al. 1994; Chen 1999).  Flow rates and cannula diameter have been the focus of 
technical optimization due to the greater risk of infection and patient discomfort of long 
infusions (Morrison et al. 1994; Chen et al. 1999; Krauze et al. 2005a; Linninger et al. 
2008).  Generally infusion occurs from narrow-diameter cannulas (26-32 gage) (Krauze 
et al. 2005a) at approximately 0.5 µL/min or lower, and then flow rate is increased 
incrementally by 0.5 or 1 µL/min to minimize reflux of infusate along the cannula track 
(Bobo et al. 1994).  Morrison first reported high-flow rate infusion without reflux at 3 
µL/min over a 12-hour period using large-MW compounds that produced an infusion 
radius of 1.5 cm (Morrison et al. 1994).  Recently, however, Krauze et al. (2005b) 
developed a “reflux-free” cannula that allows 10-fold higher flow rates without tissue 
damage or backflow as tested first in agarose gel, and then confirmed in rat and primates.  
Predictability of Vd relies on the surgeon knowing exactly how much infusate will reach 
the tissue under a properly-maintained convection pressure. 
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Another method of increasing the Vd is to increase the infusate concentration, as 
demonstrated by Kroll et al. (1996).  When flow rate and Vi are kept constant but the 
infusate concentration is increased fivefold, Vd will experience a remarkable 79% 
increase.  The authors of the study suggested that higher doses of the drug would thus 
enhance therapeutic benefit over a larger target area, which would ideally reduce the time 
required for infusion (Kroll et al. 1996).  Although short infusion times are ideal, other 
studies have investigated the effect of a long duration of infusion on the brain 
parenchyma.  Laske et al. (1997) performed 87-hour infusions into the primate brainstem 
at a moderate infusion rate of 1.7 µL/min and showed consistent and reproducible Vd.  
Despite this long infusion, only a mild astrocytic response was observed and blood 
perfusion to the infused area decreased by less than 5%.  These findings indicate that the 
principal concern of long infusions is the duration of anesthesia administration as 
opposed to the procedure itself. 
Predictability of infusate movement in the tissue is integral to proper clinical use 
of CED.  Fluid movement in gray matter versus white matter differs due to properties of 
the extracellular matrix and the cellular structures (Morrison et al. 1994, Haar 2005), and 
fluid movement through pathological brain tissue also differs from normal brain tissue 
(Haar 2005).  Gray matter parenchyma is considered homogenous and primarily consists 
of cell bodies, and has a tortuous ECM.  White matter, however, is considered 
heterogeneous and consists primarily of tracts of axonal processes surrounded by myelin 
sheaths, and has a less tortuous ECM than that of gray matter (Morrison et al. 1994, Haar 
2005).  Fluid movement through the ECS of gray matter is generally isotropic, whereas 
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fluid movement through white matter ECS occurs preferentially in parallel with the axon 
tracts and is thus anisotropic (Haar 2005).  The ratio of Vi:Vd following CED should 
presumably follow different patterns depending on the location and type of pathology 
present (Raghavan et al. 2006). 
A number of studies have set out to model infusate movement with respect to 
predicted distributions and actual distributions observed.  Published work from our lab 
has utilized gel phantoms (Chen et al. 2002) in addition to animal experimentation 
(Broaddus et al. 1998; Prabhu et al. 1998) to quantifiably model infusate distribution 
using CED.  Several quantifiable parameters affecting distribution have been cited, 
including tissue hydraulic conductivity, resting pore fraction, irreversible drug loss from 
tissue, tissue dilation, etc. (Raghavan et al. 2006).  Although formulas have been 
developed based on these variables to predict infusate movement for a given region of 
tissue, results have shown that our understanding is incomplete (Prabhu et al. 1998; 
Raghavan et al. 2006; Linninger et al. 2008).  Further understanding both of tissue 
properties and fluid movement through the tissue is thus necessary before effective CED 
can be achieved. 
Previous work in our lab investigated infusate distribution in pathological brain 
states, namely pure cytotoxic edema and pure vasogenic edema (Haar 2005).  Using the 
middle carotid artery occlusion (MCAO) model of cytotoxic edema, Haar showed that 
gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA), a mock therapeutic infusate 
distributes to a larger tissue volume in cytotoxic edema relative to normal brain in rats.  
Further, clearance of the infusate from brain with cytotoxic edema took longer than 
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clearance from normal brain.  Unfortunately, inconclusive results were observed when 
Haar infused Gd-DTPA into a model of vasogenic edema, which were in part attributed 
to intrinsic problems with the model that did not produce pure vasogenic edema.  Later, 
Shukla (2006) optimized a different model but was also unable to create edema that was 
purely vasogenic.  In response to these findings by Haar (2005) and Shukla (2006), 
purpose of this study was to optimize a different model of pure vasogenic edema. 
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Cerebral Edema 
A feature common to many brain pathologies is edema.  Such conditions include 
traumatic brain injury (TBI), intracerebral hemorrhage, brain tumors and stroke 
(Hutchinson et al. 2007).  Raslan and Bhardwaj (2007) define edema as an appreciable 
increase in brain water content.  Several subtypes have been described, although the three 
major forms are cytotoxic, vasogenic, and interstitial.  Cytotoxic edema results from 
water increase that is intracellular, whereas fluid confined to the extracellular space 
(ECS), typically as a result of serum water and proteins extravasated across a breached 
BBB, defines vasogenic edema (Klatzo 1967).  Interstitial edema is also referred to as 
hydrocephalic edema, and it results from CSF buildup that leads to hydrocephalus 
(Raslan and Bhardwaj 2007). 
A thorough understanding of edema has permitted the development of clinical 
treatments (Heiss et al. 1996), although further improvements are necessary (Raslan and 
Bhardwaj 2007).  Our lab is particularly interested in drug delivery to edematous brain 
using CED.  The goal of this study in particular is to find a reproducible model of pure 
vasogenic edema that would be appropriate for our CED investigation.  Several models of 
vasogenic edema exist, but unfortunately the edema consists of a heterogeneous mixture 
of vasogenic and cytotoxic types, which is not appropriate for our purposes. 
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Figure 1-2.  Illustrations of normal brain (A), vasogenic edema with characteristics ECS 
expansion (B), and cytotoxic edema with characteristics ECS contraction and 
intracellular swelling (C).  Figure taken from Shukla (2006). 
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Vasogenic Edema 
The late Igor Klatzo, a leader in the field of edema research, asserted that in 
normal brain, serum proteins cannot readily cross the BBB like water and electrolytes.  
Compromise of the BBB, however, will permit serum proteins and fluid to move from the 
vasculature to the brain parenchyma, hence the term vasogenic edema.  The two major 
extravasated proteins found in the ECS in this circumstance are immunoglobin G (IgG) 
and albumin (Klatzo 1987).  Proteins will remain in the ECS following resealing of the 
BBB or upon diffusion to an area with the BBB intact, maintaining an edematous state 
until they have been cleared (Kuroiwa et al. 1985; Klatzo 1987). 
Three major mechanisms of extracellular protein clearance include uptake by 
astrocytes, bulk flow to ventricles, and digestion or transport within luminal vesicles of 
endothelial cells (Klatzo et al. 1980; Klatzo 1987), although diffusion has been shown to 
play a minor role (Marmarou et al. 1990).  It was previously thought that the astrocytic 
pathway was the predominant mechanism of edema fluid clearance (Klatzo et al. 1980; 
Klatzo 1987).  However, later studies by other authors showed evidence of albumin 
clearance along perivascular spaces into the ventricles and dorsally to the subarachnoid 
space, and the authors posited that these routes provided the major clearance pathway for 
edema fluid (Ohata et al. 1990; Ohata and Marmarou 1992; Abbott 2004; Marmarou 
2007).  Astrocytic assistance in edema resolution does occur (Klatzo 1987), particularly 
via the uptake of albumin through the transforming growth factor (TGF)-β receptor 
(Ivens et al. 2007); water presumably flows into the astrocytes concurrently with the 
albumin (Klatzo 1987).  Additionally, ECS expansion is thought to put a strain on 
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metabolic needs of cells other than astrocytes (Klatzo 1987), and mechanical stress to 
their membranes, particularly in neurons at the vulnerable nodes of Ranvier, has been 
suggested to induce cellular swelling (Ohata et al. 1990).  Therefore, intracellular fluid 
uptake can latently be observed during vasogenic edema and the resultant pathology will 
be a heterogeneous mixture of vasogenic and cytotoxic forms (Klatzo 1994).   
Cytotoxic Edema 
Although cellular uptake of fluid in brain occurs predominantly in astrocytes, 
cytotoxic edema affects neurons and other cells as well.  Klatzo attributed the initial 
stages of cytotoxic edema to tissue depravation of glucose and oxygen, causing cells to 
lose control of the Na
+
/K
+
 ATPase pump.  Due to this event, the cell cannot properly 
regulate osmolarity and will begin retaining water (Klatzo 1987).  Typically ischemia, as 
seen in stroke, leads to cytotoxic edema, and the time course of cellular swelling (R 
Katzman et al. 1977) followed later by BBB disruption is well-documented (Gotoh et al. 
1985).  Experimentally, middle cerebral artery occlusion is a reproducible model of 
cytotoxic edema.  Studies of this model have revealed that the brain begins retaining Na
+
 
and water concurrent with K
+
 loss within 12 hours, and BBB permeability to albumin is 
observed between 12 to 24 hours (Gotoh et al. 1985; Hatashita and Hoff 1990).  Similar 
to vasogenic edema, cytotoxic edema temporally evolves into a heterogeneous mixture of 
these two types (Katzman et al. 1977; Gotoh et al. 1985; Hatashita and Hoff 1990; Klatzo 
1994). 
  
18 
 
 
Aquaporins 
Aquaporins (AQPs) are a recently-discovered family of transmembrane protein 
channels integral to water transport (Papadopoulos and Verkman 2007).  A diversity of 
species including bacteria and mammals express aquaporins, and they exist in many 
tissues in the human body.  The brain relies on AQPs for CSF production and for 
astrocytic regulation of water and BBB maintenance.  These channels have the capacity 
for bidirectional water transport, a feature that forms the cornerstone of an ongoing 
debate among edema researchers (Griesdale et al. 2004).  Specifically, the evaluation of 
AQP-4 in edematous brain, expressed on the astrocytic endfeet enveloping capillaries 
(Nielsen et al. 1997), as protective or harmful to the parenchyma has yet to be fully 
understood (Marmarou 2007; Papadopoulos and Verkman 2007).  Stroke models with 
overexpression (Yang et al. 2008) and knockout (Manley et al. 2000) of AQP-4 found 
that AQP-4 overexpression enhances the edema, as evidenced by respective greater and 
less edema observed in these parameters when compared to normal brain.  This channel 
has thus been implicated as a contributor to the pathogenesis of cytotoxic edema.  Indeed, 
inability of a cell to control its water is characteristic of cytotoxic edema, and AQP-4 
would not be expected to provide reprieve for the cell as a passive water channel 
(Marmarou 2007; Papadopoulos and Verkman 2007). 
In contrast to its harmful role in cytotoxic edema, Papadopoulos et al. (2004) 
found a reduction in edema and ICP in wild-type mice compared to AQP-4 -/-  mice in 
three models of vasogenic edema (intraparenchymal fluid injection, freeze lesion and 
brain tumor), suggesting a protective role in this pathology.  Freeze lesion and brain 
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tumor models induce edema through BBB breakdown and serum protein extravasation, 
whereas intraparenchymal fluid injection does not create edema through a compromised 
BBB.  This aspect highlights the role of AQP-4 as an endogenous tool that the brain uses 
to protect itself in this particular pathology.  In fact, VEGF has recently been shown to 
upregulate AQP-4 mRNA and protein expression in rats following infusion into the 
substantia nigra, which coincided with return of BBB function (Rite et al. 2008).  
Although the VEGF-induced BBB breakdown initially harms the dopaminergic neurons 
of this region (Rite et al. 2007), the authors posited that the subsequent AQP-4 
upregulation allowed the region to remove excess water as quickly as possible and 
thereby reduce the total injury volume (Rite et al. 2008).  In humans, Saadoun et al. 
(2002) reported a large upregulation of AQP-4 in reactive astrocytes of the parenchyma 
surrounding all but one of the examined high-grade astrocytomas, whereas expression in 
similar tissue surrounding low-grade astrocytomas equaled that of normal brain.  This 
finding supports the finding by Rite et al. that the brain responds in a self-protective 
fashion to vasogenic edema through upregulation of AQP-4 (Rite et al. 2008). 
Traumatic Brain Injury 
TBI has been attributed to long-term disabilities in an astounding 5.3 million 
Americans.  The pathophysiology itself is complex, and its specifics can vary depending 
on a number of factors, including the age, gender and severity of the traumatic event.  
Nevertheless, TBI pathologies have several common characteristics including 
excitotoxicity, metabolic deregulation, inflammation and edema (Keck et al. 2007).  
Edema subsequent to TBI has been shown to be heterogeneous, but with a predominance 
20 
 
 
of cytotoxic edema (Marmarou et al. 2006).  Barzó et al. (1997) describes the edema 
subsequent to TBI as biphasic, with vasogenic edema appearing in the acute stages 
followed by cellular swelling.  Following treatment of Marmarou’s impact acceleration 
model in rats, edema was observed on MRI T1 water maps for 2 weeks.  ADC values 
transiently increased up to 60 minutes post-injury before declining to below-baseline 
values, where they remained for over 2 weeks.  Ultrastructural evaluation of this model in 
the acute phase shows perivascular edema as well as astrocytic swelling (Foda and 
Marmarou 1994; Vaz et al. 1998) that persists for 24 hours but is not visible thereafter 
(Foda and Marmarou 1994). 
A notable feature of the impact acceleration model is the mild increase in blood 
pressure from 102 to 123 mmHg that decreases to hypotensive levels from 15 seconds to 
30 minutes post-injury (Marmarou et al. 1994).  Similarly, experimental fluid percussion 
injury (FPI) creates an even greater rise in blood pressure that persists over a longer time 
course (van den Brink et al. 1990; Yuan et al. 1991).  Oddly enough, edema following 
FPI persists for only 5 days post-injury (McIntosh et al. 1990).  Van den Brink et al. 
(1994) posited that the “key event” in edema formation from both FPI and impact 
acceleration, though, was damage to the vasculature including BBB breakdown and loss 
of blood pressure autoregulation. 
Intracerebral Hemorrhage 
Edema secondary to a cerebral hemorrhage can compose up to 75% of the 
perihematomal volume.  In the first 48 hours following the event, breakdown of the BBB 
due to the action of thrombin allows vasogenic edema to accompany the existing lesion.  
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Adding insult to injury, the breakdown products of the red blood cells, particularly those 
from hemoglobin, initiate an inflammatory immune response, keeping the region 
edematous (Thiex and Tsirka 2007).  It is widely believed that the edema exacerbates the 
hemorrhagic injury, largely due to the action of thrombin and its downstream effectors in 
the event cascade (Xi et al. 1999).  Yang et al. (1994) described the progression of 
cerebral hemorrhagic edema following injection of autologous blood into the rat caudate 
nucleus as similar to the edema following ischemia.  The water content increased 
progressively for 24 hours and remained constant for 5 days, after which edema began to 
decrease.  Also, the full spread of edema extended beyond the area of BBB disruption 
observed locally around the clot.   
The perihematomal area which experiences inflammation and edema has been the 
target of studies to reduce the total lesion size.  Elevated cytokines, particularly IL-6, 
IL10 and IL-1β are observed (Thiex and Tsirka 2007), with some thought to be protective 
while others are thought to be harmful.  IL-6 is thought to have a protective role through 
inhibition of MMP-9 (Cucullo et al. 2003; Vajtr et al. 2008), whereas Masada et al. 
(2003) managed to attenuate edema following both autologous blood and thrombin 
infusion with administration of IL-1 receptor antagonists (Thiex and Tsirka 2007).  
Collectively, these findings demonstrate the complexity of hemorrhagic edema, 
particularly with respect to the immune response and subsequent inflammation present in 
this brain state.  
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Peritumoral Edema 
In addition to treatment of brain tumors, treatment of peritumoral edema has also 
received a great deal of attention.  Clinical management of this complex edema correlates 
to better patient outcome following neurosurgical procedures and limits the volume of 
brain affected indirectly by the tumor (Stummer 2007).  Over time, peritumoral edema 
causes peritumoral cyst formation, as well (Baggenstos et al. 2007).  Alterations of the 
vasculature and ultimately breakdown of the BBB permit the edema formation, and 
inhibition of tumor-specific cytokines known to cause BBB breakdown, especially VEGF 
(Carlson et al. 2007; Stummer 2007) and COX-2, has been shown to attenuate 
peritumoral edema (Stummer 2007).  The vasculature displays ultrastructural evidence of 
BBB breakdown such as abnormal tight junctions, irregular basal lamina and fenestrated 
capillaries (Stewart et al. 1985; Shibata 1989; Stummer 2007).   
Experimental tumor models have provided a wealth of knowledge about the 
edema present in this pathology.  Within the tight junctions of edematous peritumoral 
vasculature, altered protein expression of occludins (Papadopoulos et al. 2001) and 
claudins (Liebner et al. 2000) has been observed, creating the paracellular portal through 
which the serum ultrafiltrate extravasates (Papadopoulos et al. 2001).  Edema generated 
locally around the tumor then spreads radially away from the tumor, mostly parallel to 
white matter tracks (Stummer 2007), as the intratumoral pressure is greater than that of 
surrounding parenchyma (Li et al. 2006).  This edema is said to be predominantly 
vasogenic because extravasated fluid resides mostly in the ECS (Papadopoulos et al. 
2004). 
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Models of Vasogenic Edema 
The literature documents many experimental models of vasogenic edema.  Many 
involve a breach of the BBB to permit extravasation of serum fluid and proteins, a 
characteristic that is observed in clinical practice as seen on MRI with gadolinium (Gd)-
enhanced T1 imaging.  However, direct intraparenchymal infusion places a proteinaceous 
fluid infusate directly into the ECS without BBB disruption (Haar 2005).  Clinical edema 
is complex and variable depending on the broader pathology, and development of various 
edema models permits accurate study of a diverse range of injuries (Haar 2005). 
Cold Lesion 
Cold lesion is a highly reproducible model of vasogenic brain edema that has 
been used since the 1950s (Bartkowski et al. 1985).  The injury is produced by placement 
of a cold metal probe onto the exposed scalp or underlying dura mater following 
craniotomy.  The severity of the lesion can vary depending on the temperature of the 
probe, typically between -68
o
C to -80
o
C (Houkin et al. 1996; Stoffel et al. 2004), and the 
duration of probe placement, which is usually 30 seconds (Papadopoulos et al. 2004; 
Stoffel et al. 2004; Nag 1996).  Following placement of the probe over the exposed skull, 
a necrotic lesion immediately forms in the brain region directly underneath the probe.  
The total lesion expands to a maximal volume at 24 hours post-operatively that is 
maintained for several days (Stoffel et al. 2004).  Apoptosis is observed for 24 hours 
within the primarily necrotic core of the lesion, but at 72 hours only the margin of the 
necrotic lesion contains apoptotic cells (Murakami et al. 1997). 
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Lesion expansion is attributed to the development of vasogenic edema 
surrounding the necrotic lesion as a result of BBB breakdown and serum extravasation.  
BBB breakdown occurs immediately post-injury and persists up to 24 hours as seen both 
from Evan’s Blue extravasation and Gd-enhanced T1 MR imaging (Houkin et al. 1996; 
Murakami et al. 1997).  Specifically, altered tight junction protein expression occurs in a 
temporal fashion.  Interestingly, caveolin-1 expression is increased up to 4 days post-
injury before returning to control level, whereas occludin and claudin-5 show varying 
levels of decrease before returning to normal (Nag et al. 2007).  Decreased expression of 
junction adhesion molecule (JAM)-A has also been observed.  Further, an important 
regulator of tight junction molecules similarly displays an altered expression profile 
following cold injury.  Both endothelial (e) and inducible (i) nitrous oxide synthase 
(iNOS) (Nag et al. 2001) are overexpressed in astrocytes (Gotoh et al. 1998) for 4 days 
after cold injury.   
Intraparenchymal Albumin Infusion 
Unlike many other models of vasogenic edema, direct intraparenchymal infusion 
creates vasogenic edema while the BBB remains intact.  Albumin, the major component 
of serum ultrafiltrate in vasogenic edema, dissolved in mock cerebrospinal fluid (CSF) is 
distributed directly to the extracellular space where it remains for 8 days as visualized by 
MRI (Fatouros et al. 1990) and TEM (Ohata et al. 1990).  Without albumin, the same 
volume of mock CSF remains only for 72 hours (Groeger and Marmarou 1989).  
Especially in comparison with other models, the edema produced is thought to be purely 
vasogenic; cellular pathology is not observed and edema clearance occurs primarily along 
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perivascular routes instead of through cellular uptake (Ohata et al. 1990).  This model has 
been used to examine pathways of protein and fluid clearance in vasogenic edema 
(Naruse et al. 1990; Ohata et al. 1990; Ohata and Marmarou 1992), and more recently by 
our lab to model infusate movement in an edematous state (Haar 2005).  Unfortunately, 
intrinsic characteristics of the model did not permit adequate results for that particular 
study. 
Mannitol 
Over the last half century, a number of studies have documented reversible BBB 
opening using hyperosmolar agents.  Due to the BBB, many therapeutic agents cannot 
reach the brain parenchyma and conventional methods of delivery have thus proven 
inadequate.  Because of their ability to reversibly open the BBB, manipulation of 
hyperosmolar agents to improve drug delivery has received a great deal of attention 
(Kroll and Neuwelt 1998; Rapoport 2000).  In addition, clinicians have used this same 
manipulation in attempts to lower acute intracranial pressure.  This technique remains 
controversial and no conclusion of its clinical effectiveness has been solidified 
(Kaufmann and Cardoso 1992; Kroll and Neuwelt 1998; Rapoport 2000). 
Clinically, a single bolus of 1.4 mM (25%) mannitol is administered to the 
internal carotid artery to induce BBB disruption that reduces edema and elevated ICP.  
Each month this can be done once a day for 2 days but for a maximum of 12 months.  
This BBB opening is mild, short-lived, and thought to attenuate an existing pathology 
where vasogenic edema is present.  From this method, the BBB remains open widely for 
40 minutes and returns to normal between 6-8 hours post-infusion (Siegal et al. 2000).  
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Experimentally, a single dose of 1.4 mM mannitol via the intracarotid infusion to healthy 
rat brain will also open the BBB.  This opening occurs maximally for 5 minutes before 
returning towards normal (Cosolo et al. 1989).  Studies from Shukla (2006) in our lab 
have shown that 3 intracarotid infusions of 1.4 mM mannitol given 30 minutes apart can 
produce extensive BBB disruption and create large edema in the rat brain.  EB 
extravasation is observed within 2 hours following the last infusion, and extensive edema 
is observed by hyperintense T2 signal on MRI throughout the ipsilateral cortex, caudate, 
and corpus callosum.  Significant mass effect is also observed.  The extensive edema 
does lead to cellular pathology within 24 hours, and many rats do not survive the 
procedure even in the acute stages (Shukla 2006).  This model does not meet the criteria 
of pure vasogenic edema, and consequently our lab sought other models. 
Vascular Endothelial Growth Factor (VEGF) 
Vascular endothelial growth factor (VEGF) is a powerful cytokine that induces 
neovascularization.  The protein was originally discovered for its ability to increase 
vascular permeability around tumors, and was therefore named vascular permeability 
factor (VPF) (Murohara et al. 1998).  VEGF upregulation occurs in most brain tumors, 
particularly in aggressive ones (Jain et al. 2007).  Blockage of VEGF by steroids (Heiss 
et al. 1996), antibodies and exogenously-applied VEGF receptors (Gorski et al. 1999) can 
effectively attenuate peritumoral edema and reduce mass effect of brain tumors (Jain et 
al. 2007).  Vascular permeability is observed within 1 minute following injection as the 
result of a leaky BBB, and neovascularization occurs much later (Dvorak 2002).  In vitro 
studies have demonstrated a biphasic nature of BBB opening due to VEGF exposure to 
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cultured vascular endothelial cells.  An initial “rapid and transient phase” occurs over the 
first 2 hours, followed by a “delayed and sustained phase” from 6-24 hours (Behzadian et 
al. 2003). 
The edema response to VEGF is largely due to the inflammatory response that it 
creates.  Croll et al demonstrated vascular leak and leukocyte after one day of continuous 
intracortical VEGF infusion via mini-osmotic pumps, and levels of both increased 
throughout the 7-day period.  The inflammatory response included increased IgG 
extravasation, leukocyte extravasation, and ICAM-1 (an important adhesion molecule in 
diapedesis).  All of these inflammatory elements contributed to the leaky vasculature that 
preceded neovascularization by several days (Croll et al. 2004).  Intraventricular delivery 
of VEGF has also been shown to induce edema and neovascularization in the 
subventricular zone.  Similar to Croll, Harrigan et al. (2003) used mini-osmotic pumps 
for continuous intraventricular VEGF infusion, and showed increase brain water content 
as well as neovascularization. 
Bile Acids 
Bile acids are cholesterol derivatives synthesized in the gut that circulate through 
the enterohepatic circulation.  Although their primary function is the emulsification of 
lipids, they assert essential roles in the biochemical regulation of glucose and lipid 
metabolism.  Bile acids exert these actions through a number of common intracellular 
signaling pathways, including protein kinase C (PKC) and FAS-receptor.  In addition, 
bile acids bind the nuclear farnesoid X receptor (FXR) through which they can affect 
other intracellular pathways (Scotti et al. 2007).  Depending on concentration and type, 
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bile acids can paradoxically promote cell (Dent et al. 2005) survival or induce apoptosis 
(Redlak et al. 2003).  Conjugated bile acids (bile acids covalently attached to taurine or 
glycine) have been shown to upregulate the cell survival proteins Akt and extracellular 
regulated kinase (ERK)1/2 in human hepatocytes; this interaction is observed in the 
normal gut and thought to be essential for proper gastrointestinal function (Dent et al. 
2005).  Alternatively, ovarian cancer cells in vitro demonstrate a dose-dependent 
apoptotic response to deoxycholic acid (DCA) (Redlak et al. 2003). 
DCA is a secondary bile acid, meaning that it is synthesized by flora in the gut 
(Scotti et al. 2007), and several studies have utilized DCA for its ability to produce brain 
edema in experimental animals (Seiffert et al. 2004).  Its relative hydrophobicity permits 
DCA to integrate into lipid membranes, from which point it is thought to alter tight 
junctions between opposing ends of vascular endothelial cells and thus permit serum 
protein and fluid extravasation (Greenwood et al. 1991; Todd et al. 1997; Seiffert et al. 
2004).  As mentioned above, bile acids (including DCA) are known to alter PKC 
signaling in many cell types of the visceral organs and also alter intracellular calcium 
fluxes in these cells (Scotti et al. 2007).  Tight junction maintenance depends on 
modulation by PKC and proper calcium regulation (Huber et al. 2001), and DCA may 
alter the tight junction integrity through those mechanisms 
Greenwood et al. (1991) showed a dose-response of DCA on RBC lysis and on 
BBB function.  RBCs exposed to increasing concentrations of DCA demonstrated that 
DCA exerted “lytic action” at 1.5 mM and above.  In a separate set of experiments, 
increasing concentrations of DCA were perfused intracarotidly with [
14
C]mannitol in 
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exsanguinated animals.  The group showed that a minimum concentration of 1.0 mM 
DCA was necessary to induce BBB disruption as evidence by mannitol extravasation 
(mannitol concentration used was not high enough to contribute to BBB disfunction).  
However, concentrations of 2.0 mM DCA and higher caused pathologic morphology in 
the vascular endothelial cells.  The authors concluded 1.0 mM DCA was the optimal 
concentration for BBB disruption while maintaining the integrity of vascular endothelial 
cells. 
Perfusion of DCA over the surface of the cortex has also been shown to induce 
BBB disruption resulting in vasogenic edema (Seiffert et al. 2004; Tomkins et al. 2007).  
A concentration of 1.0 mM DCA caused immediate albumin extravasation as evaluated 
by EB staining (Seiffert et al. 2004).  Cortical perfusion with 2.0 mM DCA caused 
albumin extravasation, as well as increased T1 and T2 signals on MRI (Tomkins et al. 
2007).  The authors also demonstrated that albumin uptake by astrocytes did not occur 
until 6-8 hours post-perfusion, suggesting that extravasated albumin remained in the 
extracellular space along with the extravasated fluid for that duration. 
The aforementioned VEGF and DCA models have not demonstrated that the 
edema produced is purely one type or a heterogeneous mixture of vasogenic and 
cytotoxic types.  We designed experiments using these two substances with the intent of 
creating pure vasogenic edema, and defined criteria to evaluate whether or not this state 
was created.  Establishment of pure vasogenic edema will permit the study of CED in this 
specific brain state by our lab, and the model can certainly be applied to other studies of 
vasogenic edema as well. 
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Chapter 2 
Hypothesis and Specific Aims 
 
Rationale: Thorough examination of many models of edema has not shown that an 
existing model can reproducibly create pure vasogenic edema.  Several new approaches 
were attempted based on existing models, such that issues with old ones were ideally 
eradicated.  We attempted to create pure vasogenic edema in the rat brain by modification 
of existing models of VEGF infusion and DCA infusion.  Further, we compared these 
models to a real case of peritumoral edema. 
  
Hypothesis I: Direct intraparenchymal infusion of VEGF will demonstrate a dose-
dependence and time-dependence on BBB disruption and edema formation in the rat 
striatum. 
Specific Aims:  
1. Establish a dose at which BBB disruption will occur. 
a) Demonstrate the time course over which BBB disruption occurs. 
2. Establish whether significant edema is produced by BBB disruption. 
a) Characterize the edema as purely vasogenic, purely cytotoxic, or 
heterogeneous 
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Hypothesis II: Direct intraparenchymal infusion of DCA will demonstrate a dose-
dependence and time-dependence on BBB disruption and edema formation in the rat 
corpus callosum. 
Specific Aims: 
1. Establish a dose at which BBB disruption will occur. 
a) Demonstrate the time course over which BBB disruption occurs. 
2. Establish whether significant edema is produced by BBB disruption. 
a) Characterize the edema as purely vasogenic, purely cytotoxic, or 
heterogeneous. 
Hypothesis III: Peritumoral edema in the rat corpus callosum is purely vasogenic. 
Specific Aims: 
1. Establish whether significant peritumoral edema exists in the corpus 
callosum of rats bearing T9 gliomas 
a) Characterize the edema as purely vasogenic, purely cytotoxic, or 
heterogeneous. 
 
 
 
 
 32 
 
 
 
Chapter 3 
Methods 
 
All animal experiments were approved by the Committee for the Care and Use of 
Laboratory Animals at Virginia Commonwealth University.  Male Sprague-Dawley rats 
(Harlan, Indianapolis, Indiana) with an average weight range of 300 – 350 grams were 
used for all infusions of saline, VEGF, and DCA.  Methods used were similar or equalent 
to those used by Haar (2005), Shukla (2006), and Parry (2007).  In addition to these 
groups, brain tissue from female Fisher 344 rats (Harlan, Indianapolis, Indiana) weighing 
approximately 140 grams and bearing T9 glioma tumors was donated by Dr. Zhi-jian 
Chen from his experiments; methods for surgery, tumor implantation, sacrifice, and tissue 
processing in these animals are summarized under the heading “Donation of Tumor-
Bearing Rats” at the end of this chapter. 
Stereotactic Infusion 
Male Sprague-Dawley rats were anesthetized by intraperitoneal administration of 
90 mg/kg ketamine : 10 mg/kg xylazine (10 : 1 mixture of ketamine [100 mg/mL] : 
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xylazine [50 mg/mL]).  Lubricating veterinary ointment was applied to the eyes and the 
animal was placed on a heating pad in a stereotactic frame.  A 10 mm midline incision 
was made at the scalp, centered approximately at bregma.  An infusion burr hole was 
stereotactically created 3mm lateral, 1mm posterior to bregma using a roto-tool and fine 
drill bit for all infusions.  A 28-gague needle attached to a 100 µL Hamilton syringe 
driven by a syringe pump (Bioanalytical Systems, West Lafayette, Indiana) was lowered 
6mm below the surface of the brain for striatum infusions and 2.5 mm below the surface 
of the brain for corpus callosum infusions and remained in the brain parenchyma for 5 
minutes before infusion.  Five minutes after infusion, the infusion needle was slowly 
raised 1 mm every minute until out of the brain.  The incision was then closed with 
absorbable chromic gut, averaging 6 interrupted sutures along the length of the incision 
and the rat was placed under a heat source and monitored until alert and mobile.  Animals 
sacrificed less than 24 hours post-operatively were not given analgesic.  For animals 
sacrificed 24 hours or longer post-operatively, buprenorphine (0.03 mL, 0.3 mg/mL) was 
administered subcutaneously every 12 hours up to 72 hours. 
20 µL of 0.1 µg/mL, 1 µg/mL, and 5 µg/mL VEGF in PBS was infused into the 
right striatum  at a flow rate of 0.25 µL/min for 80 minutes and given intravenous Evan’s 
Blue (EB) dye before being sacrificed at 1 hour post-infusion  (n=2 for each 
concentration).  Brains were then harvested and then grossly section in the coronal plane 
at the needle track with a razor blade to look for EB staining.  Brain tissue at needle tract 
was then stained with hematoxylin and eosin by the Department of Anatomic Pathology 
at Virginia Commonwealth University, Richmond, Virginia.  A parallel set of animals 
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(n=2) received 20 µL of 0.1 µg/mL VEGF in PBS, and was given EB before sacrifice at 
20 hours post-infusion.  These brains received gross sectioning as previously described, 
but were not stained with hematoxylin and eosin.   
 6 and 12 µL of DCA was infused at 2.0 mM in 0.9% saline into the right striatum 
at a flow rate of 0.2 µL/min for 30 and 60 minutes, respectively.  Animals (n=2 per 
volume group) were given EB and sacrificed at 1 hour, after which brains received gross 
sectioning, as described above for stereotactic VEGF infusion.  For a second group, 6, 9, 
12, and 18 µL of DCA was infused at 2.0 mM in 0.9% saline into the right corpus 
callosum at a flow rate of 0.2 µL/min for 30, 45, 60, and 90 minutes, respectively.  
Animals (n=2 per volume group) were given EB and sacrificed at 1 hour, after which 
brains received gross sectioning as described above for stereotactic VEGF infusion.  A 
third set of animals (n=2 per time group) received 18 µL of 2.0 mM DCA and were given 
EB and sacrificed 5 hours, 1 day, 1 week, and 2 weeks post-infusion.  Brains were 
examined by gross sectioning.  A fourth set of animals (n=2) received 9 µL of 2.0 mM 
DCA were sacrificed 1 hour post-infusion.  Brains were sectioned by vibratome and 
parallel samples were processed for GFAP immunohistochemistry and electron 
microscopy  preparation, as described below.  2 more animals received 9 µL of 2.0 mM 
DCA and were saved for MRI at 1 day post-infusion, after which animals were sacrificed. 
Brains were sectioned by vibratome and parallel samples were processed for GFAP 
immunohistochemistry and electron microscopy  preparation. 
6 and 12 µL of 1.0 mM DCA in saline was infused into the right striatum at a 
flow rate of 0.2 µL/min for 30 and 60 minutes, respectively.  Animals (n=2 per volume 
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group) receiving 6 and 12 µL were given EB and sacrificed at 1 hour, after which brains 
were examined by gross sectioning.  In a separate experiment, 6, 9, and 12 µL of 1.0 mM 
DCA in saline was infused into the right corpus callosum at a flow rate of 0.2 µL/min for 
30, 45, and 60 minutes, respectively.  Animals (n=2 per volume group) receiving 6 and 
12 µL of 1.0 mM DCA were given EB and sacrificed at 1 hour, after which brains were 
examined by gross sectioning.  Animals (n=2 per time group) receiving 9 µL of 1.0 mM 
DCA were given EB and sacrificed at 1 hour and 1 day, after which brains were 
sectioned by vibratome and parallel samples were processed for GFAP 
immunohistochemistry and electron microscopy preparation. 
9 µL of 0.5 mM DCA was infused at a flow rate of 0.2 µL/min for 45 minutes.  
One group of animals (n=3) receiving 0.5 mM DCA was saved for MRI 1 hour and then 
sacrificed.  A second group of animals (n=3) receiving 0.5 mM DCA was saved for MRI 
at 1 day and then sacrificed.  A third group of animals (n=2) receiving 0.5 mM DCA was 
given EB and sacrificed at 1 hour.  A fourth group of animals (n=2) receiving 0.5 mM 
DCA was given EB and sacrificed at 1 day.  For the third and fourth groups, brains were 
sectioned by vibratome and parallel samples were processed for GFAP immunohisto-
chemistry and electron microscopy  preparation. 
18 µL of 0.9% saline (vehicle) was infused at a flow rate of 0.2 µL/min for 90 
minutes into the right corpus callosum.  Animals (n=2) were sacrificed at 1 hour post-
infusion, and brains were sectioned by vibratome and parallel samples were processed for 
GFAP immunohisto-chemistry and electron microscopy  preparation. 
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Osmotic Pump Implantation 
Alzet mini-osmotic pumps (DURECT Corporation, Cupertino, California) were 
filled with 200 µL of 1 µg/mL VEGF in PBS, and Alzet micro-osmotic pumps 
(DURECT Corporation, Cupertino, California) were filled with 90 µL of 1 µg/mL VEGF 
in PBS.  Pumps were attached to Alzet brain infusion kit II (DURECT Corporation, 
Cupertino, California) and primed by incubation in sterile 0.9% saline at 37
o
C for 24 
hours before implantation. 
Each rat was anesthetized by intraperitoneal administration of 90 mg/kg ketamine 
: 10 mg/kg xylazine (10 : 1 mixture of ketamine [100 mg/mL] : xylazine [50 mg/mL]).  
Lubricating veterinary ointment was applied to the eyes and the animal was placed on a 
heating pad in a stereotactic frame.  A 10 mm midline incision was made at the scalp, 
centered approximately at bregma.  An infusion burr hole was stereotactically marked 
3mm lateral, 1mm posterior to bregma.  From the posterior of the incision site, 
subcutaneous pocket was made and the pump was placed inside.  Then, the first burr hole 
was created 3 mm posterior to the infusion mark using a roto-tool and fine drill bit.  The 
burr hole was manually threaded with a metal screw, the rise of which was calculated and 
compared to the thickness of the skull to prevent injury to the brain.  The cannula of the 
brain infusion kit was placed onto the infusion burr hole and temporarily fixed with 
superglue.  After 5 minutes, the stereotactic arm was raised, and dental cement (Hygenic, 
Akron, OH) was applied around the base of the guide cannula and nylon screw.  
Allowing enough time to set, the incision was then closed with absorbable chromic gut, 
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averaging 6 interrupted sutures along the length of the incision.  Buprenorphine (0.03 
mL, 0.3 mg/mL) was administered subcutaneously every 12 hours up to 72 hours. 
Animals (n=2) receiving micro-osmotic pump implantation were given EB and 
sacrificed at 3 days post-implantation, and animals (n=2) receiving mini- osmotic pump 
implantation were given EB and sacrificed at 3 days post-implantation.  All brains were 
harvested and examined by gross sectioning, as described above. 
Evan’s Blue Dye Injection 
EB dye was utilized to mark BBB disruption on all rats and brains were examined 
when sectioned.  EB dye (2% in saline) was delivered at 2ml/kg via the penile vein 
within 1 hour prior to sacrifice. 
Sacrifice and Perfusion 
Euthasol (150 mg/kg plus 19 mg/kg phenytoin) was administered by 
intraperitoneal injection following IACUC guidelines.  The rat was transcardially 
perfused through a blunt, large-bore needle placed into the left ventricle and positioned 
within the ascending aorta.  Approximately 400 mL of normal saline (0.9%) was used to 
flush the vasculature, followed by approximately 400 mL of fresh 4% paraformaldehyde.  
Brains were harvested and placed in fresh 4% paraformaldehyde for 48 hours, after which 
they were removed, washed with Millonig’s solution, and stored in the latter solution 
until processing for LM or EM studies. 
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Light Microscopy Preparation 
Selected samples for LM study were cut via vibratome into consecutive 50 µm 
thick slices.  From each block, approximately 3 slides of 4 sections each were sampled at 
-0.4, 0, and +0.4 mm relative to the infusion site (0).   
Tissue Preparation for Immunohistochemistry Analysis 
Semi-serial coronal sections were used for single label immunohistochemistry 
analysis.  These sections were rinsed 3 X 10 minutes in PBS and endogenous peroxidase 
activity was blocked with 0.3% H2O2 in PBS for 30 min.  Sections were rinsed 3 X 10 
min in PBS, and pre-incubated for 60 min with 0.2% Triton X (Sigma Chemical Co., St. 
Louis, MO) in 10% normal goat serum (NGS)/PBS.  The tissue was then incubated 
overnight in mouse anti-glial fibrilllary protein (GFAP) antibody at a dilution of 1:1,500 
(Zymed Laboratories) in 1% NGS/PBS at a dilution of 1:600.  After 3 X 10 min washes 
in PBS containing 1% NGS, the sections were incubated in a 1:200 dilution of or 
biotinylated anti-mouse rat adsorbed immunoglobulin (diluted 1:200 in 1% NGS/PBS 
(Vector, Burlingame, CA) for 60 min followed by 3 X 10 min rinses in PBS.  After 
incubation in an avidin-biotin peroxidase complex (ABC standard Elite kit, Vector, 
Burlingame, CA) at a dilution of 1:200 for 60 min and rinsing in PBS and 0.1 M 
phosphate buffer 3 X 10 min, the sections were processed for visualization of the 
immunohistochemical complex using 0.05% diaminobenzidine (DAB) (Sigma Chemical 
Co., St. Louis, MO), 0.01% hydrogen peroxide, 0.3% imidazole in 0.1 M PBS.  Next the 
sections were mounted, serially, on gelatin-coated glass slides, dehydrated and cover-
slipped.   
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Qualitative Representation of GFAP Immunoreactivity 
Tissue stained for GFAP was visualized using the Nikon E800 M Eclipse 
Microscope with SpotRT camera (Diagnostic Instruments), which was used for image 
acquisition.  Microscopy was performed at the VCU – Dept. of Anatomy & 
Neurobiology Microscopy Facility, supported, in part, with funding from NIH-NINDS 
Center core grant (5P30NS047463).  Slides stained for GFAP were qualitatively assessed 
according to morphological characteristics.  At 4x and 20x magnification, the corpus 
callosum was inspected for evidence of dark, interconnecting astrocytic processes, the 
presence of which was defined as a GFAP increase. 
Transmission Electron Microscopy Preparation 
Selected samples for electron microscopy (EM) study were taken from parallel 
sampling sites as those used in LM preparation.  Selected slices were washed with 0.1M 
Sorensen's phosphate buffer at 4°C then postfixed with 1% osmium tetroxide in 0.1M 
phosphate buffer at 4°C for 1 hour. Samples were then washed with buffer and 
dehydrated with a cold ethanol series: 50%, 70%, 80%, and 95%, for 5 minutes each. 
Next, slices were dehydrated with 100% ethanol at 20°C, followed by 3 changes of 100% 
propylene oxide for 10 minutes each. Slices were placed in a 1:1 propylene 
oxide:PolyBed solution for 4 hours, and then transferred to pure PolyBed resin overnight. 
Each section was embedded on vinyl slides and placed in a 60°C oven overnight.  After 
LM examination, sections were chosen and excised from the cortical and deep gray 
region for remounting on blocks and further sectioning. Using the LKB 2120 
Ultramicrotome, 900Å sections were cut with a diamond knife. Each section was then 
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placed on Formvar-coated slotted grids and stained with uranyl acetate and lead citrate 
for TEM study. A JEOL JEM-1230 (JEOL USA, Inc.) transmission electron microscope 
was used to capture images via the Ultrascan 4000 camera (Gatan, Inc.). 
  
41 
 
 
Magnetic Resonance Imaging 
Implantation of Guide Cannula 
Rats were anesthetized by intraperitoneal administration of 90 mg/kg ketamine : 
10 mg/kg xylazine (10 : 1 mixture of ketamine [100 mg/mL] : xylazine [50 mg/mL]).  
Lubricating veterinary ointment was applied to the eyes and the animal was placed on a 
heating pad in a stereotactic frame.  A 10 mm midline incision was made at the scalp, 
centered approximately at bregma.  an infusion burr hole was stereotactically marked 
3mm lateral, 1 mm posterior to bregma for all in-bore infusions.  The first burr hole was 
created 3 mm posterior to the infusion mark using a roto-tool and fine drill bit.  The burr 
hole was manually threaded with a metal screw, the rise of which was calculated and 
compared to the thickness of the skull to prevent injury to the brain.  A nylon screw 
(PlasticsOne, Roanoke, VA) was placed into this hole and the infusion burr hole was then 
created.  An outer guide cannula (PlasticsOne, Roanoke, VA) containing a stylette was 
placed onto the infusion burr hole and temporarily fixed with superglue.  Several minutes 
following, the stereotactic arm was raised, and dental cement (Hygenic, Akron, OH) was 
applied around the base of the guide cannula and nylon screw.  Allowing enough time to 
set, the incision was then closed with absorbable chromic gut, averaging 6 interrupted 
sutures along the length of the incision.  The stylette was removed from the guide cannula 
and a dummy cap – previously cut to match the length of the guide – was placed into the 
guide.  Buprenorphine (0.03 mL, 0.3 mg/mL) was then administered subcutaneously 
every 12 hours up to 72 hours, with the rat placed under a heat source and monitored until 
alert and mobile.   
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In-bore Infusion 
Each rat to be scanned was either kept under isoflurane anesthesia if imaging was 
conducted on the same day as DCA or saline infusion, or anesthetized by intraperitoneal 
administration of 90 mg/kg ketamine : 10 mg/kg xylazine (10 : 1 mixture of ketamine 
[100 mg/mL] : xylazine [50 mg/mL]) for all subsequent follow-ups.  After baseline 
scanning, a 6 mm infusion needle (PlasticsOne, Roanoke, VA) was lowered into the 
guide cannula such that the tip of the needle was 3 mm below the surface of the brain.  A 
volume of 9 µL (n=3) of 2.0 mM DCA in saline was infused into the right corpus 
callosum at a flow rate of 0.2 µL/min for 45 minutes with one group of rats (n=3). 
Animals were scanned for up to 3 hours post-infusion, such that T2-weighted, diffusion-
weighted, T1-weighted images were taken sequentially every 30 minutes.  The infusion 
needle remained in the animal for post-infusion scanning and the guide cannula was re-
capped after the final scan.  The rat was then placed under a heat source and monitored 
until alert and mobile.   One of these animals was received follow-up scanning at 1 day, 5 
days, and 7 days post-infusion. A second animal received follow-up scanning at 1 day.  
The third died between 2-3 hours post-infusion.  After scanning, animals were placed 
under a heat lamp and monitored until normal respiration had returned before extubation.  
Animals were then monitored until awake and alert before being placed by in the 
vivarium. 
Imaging Following Stereotactic Infusion 
All animals that were examined by MRI following stereotactic infusion were 
anesthetized by intraperitoneal administration of 90 mg/kg ketamine : 10 mg/kg xylazine 
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(10 : 1 mixture of ketamine [100 mg/mL] : xylazine [50 mg/mL]).  Each animal received 
was subjected to a single set of T2-weighted, diffusion-weighted, T1-weighted images.  
Although described above in the stereotactic infusion section, a brief summary is 
provided.  From the 9 µL of 2.0 mM DCA infusion group, 2 animals received scaning at 
1 day post-infusion.  From the 9 µL of 1.0 mM DCA infusion group, 3 animals received 
scaning at 1 hour post-infusion and 3 additional animals received scanning at 1 day.  
Similarly, 3 animals received scaning at 1 hour post-infusion and 3 additional animals 
received scanning at 1 day following infusion of 9 µL of 0.5 mM DCA. 
Imaging Placement 
Each rat to be scanned was either kept under isoflurane anesthesia for in-bore 
infusion, or anesthetized by intraperitoneal administration of 90 mg/kg ketamine : 10 
mg/kg xylazine (10 : 1 mixture of ketamine [100 mg/mL] : xylazine [50 mg/mL]) when 
scanning occurred following stereotactic infusion and for all subsequent follow-ups.  
Each rat was placed in an acrylic imaging tube, secured via plastic ear bars, and fitted 
with a surface coil.  Images were acquired with a 2.4 T, 40-cm bore magnet (Bruker 
Medical, Inc., Billerica, MA) equipped with a 12 cm inner-diameter, actively shielded 
gradient insert (maximum gradient strength: 25 G/cm).  An actively decoupled RF coil 
set was used for RF excitation/reception and was comprised of a 7 cm inner-diameter 
“birdcage” design resonator and a 2 cm diameter circular surface coil.   
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T2 images 
T2-weighted images with echo time (TE) of 100 msec, and repetition time (TR) of 
3000 msec, were obtained on 5 contiguous coronal slices 2-mm thick with a resolution of 
96 by 96.   
EPI DWI 
DWI (TR: 1500 msec/ TE: 41msec) images were taken which employed an echo 
planar based spin echo sequence appropriately modified to include diffusion-sensitizing 
gradients along the readout (horizontal) direction with a duration of 9msec and a gradient 
separation of 20 msec.  Each data set consisted of 5 coronal slices of the forebrain and 
midbrain region, each slice being 2-mm thick with a resolution of 128 by 128 and a 30-
mm
2
 field of view. Diffusion weighting factors, or b values of 0 and 1042s/mm
2
 were 
used (maximum gradient strength of 23 G/cm). ADC maps were processed from DWI 
images using the MRVision software package (MRVision Co., Winchester, MA).   
SE DWI 
DWI (TR: 1500 msec/ TE: 39 msec) images were taken which employed a spin 
echo sequence appropriately modified to include diffusion-sensitizing gradients along the 
readout (horizontal) direction with a duration of 4 msec and a gradient separation of 25 
msec.  Each data set consisted of 5 coronal slices of the forebrain and midbrain region, 
each slice being 2-mm thick with a resolution of 128 by 128 and a 30-mm
2
 field of view. 
Diffusion weighting factors, or b values of 4.2, 160.5, 557.6, and 1195.6 s/mm
2
 were 
used (maximum gradient strength of 23 G/cm). ADC maps were processed from DWI 
images using the MRVision software package (MRVision Co., Winchester, MA).   
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T1 images 
A two-dimensional T1 imaging series was generated with a spin echo, echo-
planar imaging sequence preceded by an inversion recovery preparation period using a 
hyperbolic secant inversion pulse.  Data was obtained on 3 coronal sections at a thickness 
of 2.5mm and slice separation of 3.0mm.  Inversion recovery times were: 30, 60, 150, 
300, 700, 1300, and 2500 msec.   
Data Analysis 
Average T1 and ADC values were obtained from regions-of-interest (ROI) 
outlined in the corpus callosum from the slice containing the cannula track. T1 Maps 
were calculated from the inversion recovery images.  These T1 maps were converted to 
water maps by means of the following equation (Fatouros and Marmarou 1999) using the 
MRVision software: 
fw = [T1 / (0.407 + 0.907*T1)]*100 
 
Here fw is the percent water content.  This formula is applicable at a field strength of 2.4 
T.  Mean fw and ADC values from edematous regions for each infusate concentration and 
time period were compared to contralateral brain using t-tests and graphical analysis. 
Donation of Tumor-Bearing Rats 
Brain tissue from T9 glioma-bearing female Fisher 344 (Harlan, Indianapolis, IN) 
rats (weighing approximately 120 – 140 grams) was donated by Dr. Zhi-jian Chen.  Two 
of the animals had been tumor-bearing for 22 days, and one of the animals had been 
tumor-bearing for 15 days.  Tissue was sectioned on a vibratome and parallel sections 
were processed for GFAP and EM as described above for each animal. 
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T9 glioma cells were given to Dr. Chen by Dr. Martin Graf (Department of 
Neurosurgery, Virginia Commonwealth University, Richmond, Virginia).  Cells were 
cultured in DMEM supplemented with 10% FBS and non-essential amino acids, as 
adherent monolayers at 37
o
C, and passed biweekly with trypsin in the absence of 
antibiotics. Cell lines were routinely screened for mycoplasma contamination (MycoTect, 
Gibco BRL). All tissue culture reagents and supplements were obtained from Gibco BRL 
(Grand Island, NY) unless noted otherwise. Monolayers of tumor cells were trypsinized, 
counted on a hemacytometer and viability was assessed by trypan blue exclusion. Cells 
were washed twice in phosphate buffered saline (PBS) and the concentration was 
adjusted appropriately (Graf et al. 2005). 
Before tissue donation to this project, each rat received implantation of a guide 
cannula as described above, and after 24 hours was infused with 5 x 10
4
 T9 glioma cells 
into the right striatum (Graf et al. 2005).  Cells were permitted to grow for 1 week before 
MRI scanning to confirm tumor formation.  Two animals received follow-up scans up to 
21 days post-infusion of T9 cells, and the third received follow-up scans up to 14 days 
post-infusion.  For follow-up scans, animals were anesthetized as previously described, 
but were also administered Gd-DTPA intravenously through the lingual vein before 
scanning for enhancement on T1-weighted images.  For the purposes of this study, T2-
weighted images and Gd-enhanced T1-weighted images and were analyzed.  All animals 
were sacrificed by transcardial perfusion and tissue was fixed with 4% paraformaldehyde 
as described above at 1 day after the final follow-up MRI scans.  After brains were 
harvested, they were donated to this project for aforementioned tissue processing.  For 
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analysis in this study, qualitative examination was performed on T2-weighted images, 
Gd-enhanced T1-weighted images, tissue stained for GFAP, and tissue processed for EM. 
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Chapter 4 
Results 
 
VEGF 
Blood-Brain Barrier Integrity 
VEGF was infused stereotactically into the striatum, and infusions with micro-and 
mini-osmotic pumps were also performed into the cortex.  BBB integrity was then 
evaluated by gross sectioning of the brain to visualize EB staining following intravenous 
administration.  No EB extravasation, as demonstrated in Figure 4-1, A, was observed 
ipsilaterally or contralaterally following stereotactic infusion of 0.1 µg/mL VEGF at 1 
and 20 hours, 1 µg/mL VEGF at 1 hour, and 5 µg/mL VEGF at 1 hour.  Similarly, no 
ipsilateral or contralateral EB stain was observed following 1 µg/mL VEGF infusion both 
through micro-osmotic pumps after 3 days, and mini-osmotic pumps after 5 days.  It was 
also noted that needle tracts and cannula tracts (ipsilateral) from all infusions showed no 
evidence of EB extravasation. 
Hematoxylin and Eosin Staining 
Hematoxylin and Eosin (H&E) stains were also performed on representative 
tissue from all stereotactic infusion parameters by the department of anatomical 
pathology.  No Virchow-Robins spaces or other evidence of fluid extravasation was   
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Figure 4-1.  Representative images showing a brain with no Evan’s Blue Dye 
extravasation (A) following VEGF infusion compared to a brain infused with 2.0mM 
DCA where Evan’s Blue Dye extravasation was present (B).  Blue color in (B) shows 
extravasated Evan’s Blue bound to serum proteins in the corpus callosum on the left side 
of the image. 
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Figure 4-2. Photomicrograph of H&E-stained ipsilateral striatum following stereotactic 
infusion of 0.1 µg/mL VEGF.  Red blood cells in needle tract noted with arrow. 
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observed ipsilaterally or contralaterally in any tissue sample.  Needle tract containing red 
blood cells was observed ipsilaterally in representative tissue for 1 hour post-infusion of 
0.1 µg/mL VEGF (Figure 4-2). 
Deoxycholic Acid 
Blood-Brain Barrier Integrity 
EB extravasation was observed by gross brain sectioning in the ipsilateral corpus 
callosum following 30-, 45- and 60-minute infusion of 2.0 mM DCA (Figure 4-1, B).  
For this same concentration, 30- and 60- minute infusion into the striatum also 
demonstrated EB extravasation.  Gross brain sectioning of 1.0 mM DCA infusion did not 
show EB extravasation in ipsilateral corpus callosum (30-minute infusion), but 30-minute 
infusion of this same concentration into the striatum did show EB extravasation 
ipsilaterally.  However, EB extravasation was observed at 1 hour post-infusion of 1.0 mM 
DCA in the ipsilateral corpus callosum in sections containing needle tract when 
sectioning tissue on the vibratome; it was thereby determined that 45-minute infusion of 
1.0 mM DCA caused EB extravasation.  1 day post-infusion of 1.0 mM DCA, no EB 
extravasation was observed.  No EB extravasation in the ipsilateral or contralateral 
corpus callosum was observed following 45-minute infusion of 0.5 mM DCA upon gross 
sectioning or vibratome sectioning at 1 hour and 1 day post-infusion. 
Stereotactic saline infusion into the corpus callosum over 90 minutes did not show 
EB extravasation upon gross sectioning or vibratome sectioning when animals were 
sacrificed at 1 hour post-infusion. 
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Table 4-1. Table demonstrating observed EB extravasation in the corpus callosum for 
groups of rats receiving 9 µL of 0.5 mM, 1.0 mM, or 2.0 mM DCA infusion when 
examined at 1 hour and 1 day.  No observed EB staining is indicated by (-).  Observed 
EB staining is indicated by (+). 
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 1 Hour 1 Day 
Contralateral 
 
- - 
Ipsilateral 
0.5 mM DCA 
- - 
Ipsilateral 
1.0 mM DCA 
+ - 
Ipsilateral 
2.0 mM DCA 
+ - 
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Magnetic Resonance Imaging 
T2 Imaging  
T2 images from representative animals are presented in Figure 4-3, showing 1 
hour and 1 day post-infusion of 0.5 mM, 1.0 mM, and 2.0 mM DCA.  Infusion of 0.5 mM 
DCA produced hyperintensity in the ipsilateral corpus callosum at 1 hour post infusion.  
Lateral extension of the hyperintensity from the site of infusion was observed as seen in 
the 2.0 mM DCA group described above; no medial extension across the midline was 
observed.  By 1 day, no ipsilateral hyperintensity was apparent in any animals.  
Contralaterally, no hyperintensity for the same area of the corpus callosum was apparent 
in any animal for each time point. 
Infusion of 1.0 mM DCA produced hyperintensity in the ipsilateral corpus 
callosum at 1 hour post infusion.  Lateral extension of the hyperintensity from the site of 
infusion was observed as seen in the 2.0 mM DCA group described above; no medial 
extension across the midline was observed.  By day 1, similar ipsilateral hyperintensity 
was observed in 1 animal but not in the other two.  In addition, hyperintensity along the 
needle tract was observed in this animal and another animal.  Contralaterally, no 
hyperintensity for the same area of the corpus callosum was apparent in any animal for 
each time point. 
Following 45-minute infusion of 2.0 mM DCA, T2 hyperintensity was observed 
in the ipsilateral corpus callosum in all animals at 1 hour.  The observed hyperintensity 
was localized to the corpus callosum such that the hyperintensity extended primarily in a   
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Figure 4-3.  T2-weighted MR images following infusion of 0.5 (A, B), 1.0 (C,D), and 
2.0 (E, F) mM DCA at 1 hour (A, C, E) and 1 day (B, D, F).  At 1 hour post-infusion, all 
concentration groups display T2 hyperintensity in the ipsilateral (right side of image) 
corpus callosum.  Only the 2.0 mM DCA group displays ipsilateral T2 hyperintensity at 1 
day post-infusion.  
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DCA 
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lateral fashion from the infusion site.  However, in one animal there was medial extension 
slightly beyond the midline axis of the brain in addition to the lateral extension.  By 1 
day, the ipsilateral corpus callosum also exhibited hyperintensity, and was confined to a 
lateral extension from the site of infusion without cross of the midline. Contralaterally, no 
hyperintensity for the same area of the corpus callosum was apparent in any animal for 
each time point. 
Water Content 
The location of each region selected for water content measurement was dictated 
by the area of T2 hyperintensity ipsilaterally and by the symmetrical region on the 
contralateral side.  Graphs of water content for each DCA dose are seen at the tops of 
Figure 4-4 for 1 hour post-infusion and Figure 4-5 for 1 day post-infusion. 
Infusion of 0.5 mM DCA over 45 minutes produced higher average water content 
in the ipsilateral corpus callosum (76.0%) relative to contralateral 71.7%) but the 
difference in these values did not attain significance (p=0.088).  For this same treatment, 
the ipsilateral and contralateral corpus callosum did not show a significant difference in 
water content 1 day post-infusion.  Average values for ipsilateral and contralateral were 
72.5% and 72.5%, respectively. 
Infusion of 1.0 mM DCA over 45 minutes produced significantly higher 
(p=0.014) ipsilateral water content of 77.1% compared to 71.8% of the contralateral 
corpus callosum at one hour post-infusion.  1 day following this same treatment, 
ipsilateral and contralateral water contents were 76.4% and 73.4%, respectively, but the 
difference in these values did not attain significance.  
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Figure 4-4.  Graphs displaying percent water (top) and ADC values (bottom) for the 
contralateral and ipsilateral corpus callosum at 1 hour post-infusion of DCA.  The 
ipsilateral corpus callosum for 1.0 and 2.0mM DCA has significantly higher percent 
water, indicating the presence of edema.  Furthermore, all ipsilateral ADC values are 
significantly higher than contralateral, suggesting a predominance of vasogenic edema 
following 1.0 and 2.0mM DCA infusion.  The ipsilateral corpus callosum following 
0.5mM DCA infusion does not demonstrate significant increase in percent water content, 
but does show significant increase in ADC.  
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Figure 4-5.  Graphs displaying percent water (top) and ADC values (bottom) for the 
contralateral and ipsilateral corpus callosum at 1 day post-infusion of DCA.  The 
ipsilateral corpus callosum for 2.0mM DCA has significantly higher percent water, 
indicating the presence of edema.  Furthermore, significantly higher ADC values for this 
group suggest the predominance of vasogenic edema.  The 0.5 and 1.0 mM DCA groups 
show no significant increase in percent water or ADC.  
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Following in-bore (infusion inside the MRI on cannulated animals, as previously 
described in the methods section) 45-minute infusion of 2.0 mM DCA, water content of 
the ipsilateral corpus callosum was increased significantly (p=0.035, n=3) relative to the 
contralateral corpus callosum at 1 hour post-infusion.  Average ipsilateral water content 
was 76.1% compared to 70.9% for contralateral.  One of these animals was also used in 
conjunction with two additional animals that received 45-minute stereotactic infusions on 
the benchtop (as used in 0.5 mM and 1.0 mM DCA infusions) of 2.0 mM DCA to assess 
water content and ADC values 1 day post-infusion.  At this time point, water content of 
the ipsilateral corpus callosum was 77.3%, which was significantly higher (p=0.0041) 
than contralateral at 72.0%. 
Apparent Diffusion Coefficient 
The location of each region selected for ADC measurement was the same as those 
used to measure water content, as dictated by T2 imaging.  Graphs of ADC for each DCA 
dose are seen at the tops of Figure 4-4 for 1 hour post-infusion and Figure 4-5 for 1 day 
post-infusion. 
Following 0.5 mM DCA infusion, ADC of the ipsilateral corpus callosum was 
significantly higher (902 cm
2
/sec x 10
-6 
and 647 cm
2
/sec x 10
-6
, respectively; p=0.030) 
than contralateral.  Ipsilateral and contralateral ADC measurements were not significantly 
different at 1 day. Average ipsilateral and contralateral ADCs were 723 cm
2
/sec x 10
-6 
and 702 cm
2
/sec x 10
-6
, respectively. 
For the 1.0 infusion group, the changes in ADC occurred in a similar fashion to 
water content changes.  Average ADC of the ipsilateral corpus callosum (834 cm
2
/sec x 
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10
-6
) was significantly higher (p=0.036) at 1 hour post-infusion than contralateral (663 
cm
2
/sec x 10
-6
).  Measurement at 1 day showed average ADC of the ipsilateral corpus 
callosum to be higher than contralateral, but the difference in these values did not attain 
significance.  Average ipsilateral and contralateral ADCs were 811 cm
2
/sec x 10
-6 
and 
704 cm
2
/sec x 10
-6
, respectively. 
ADC for the 2.0 mM DCA infusion group were significantly higher in the 
ipsilateral corpus callosum relative to contralateral at both 1 hour (p=0.0049) and 1 day 
(p=0.0013).  Average ipsilateral and contralateral ADCs at 1 hour were 945 cm
2
/sec x 10
-
6
 and 728 cm
2
/sec x 10
-6
, respectively, and at 1 day were 955 cm
2
/sec x 10
-6
 and 710 
cm
2
/sec x 10
-6
, respectively. 
GFAP Staining 
In the corpus callosum contralateral to infusion, no difference in GFAP staining 
was observed between 1 hour and 1 day post-infusion for all doses of DCA.  Further, no 
morphological characteristics of GFAP upregulation were visible.  Cell bodies and 
astrocytic processes were occasionally visible, and no interconnecting processes were 
observed. The rats receiving saline infusion showed similar GFAP staining in the 
contralateral and ipsilateral corpus callosum, both of which were similar to contralateral 
corpus callosum GFAP staining in DCA-infused animals.  Figure 4-6 shows GFAP 
staining in representative photomicrographs of each dose and time parameter at 4x 
magnification.  Figure 4-7 shows 20x magnification of the same images seen in Figure 
4-6. 
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The ipsilateral corpus callosum following 0.5 mM DCA displayed no evidence of 
GFAP upregulation at both 1 hour and 1 day post-infusion.  The region of interest did not 
appear darker at 4x magnification, and at 20x magnification no morphological difference 
relative to control or ipsilateral corpus callosum outside of the region was observed. 
GFAP staining within the ipsilateral region of interest following 1.0 mM DCA 
was no different from contralateral at 1 hour post-infusion, both at 4x and 20x 
magnification.  At 1 day, dark GFAP staining was observed when viewed at 4x 
magnification, and visualization at 20x magnification showed dark staining but no 
interconnecting astrocytic foot processes. 
Ipsilateral to infusion of 2.0 mM DCA, astrocytes of the corpus callosum 
displayed morphological characteristics of GFAP upregulation at both 1 hour and 1 day 
post-infusion within the same region of interest as that of MRI studies.  At 4x 
magnification, dark GFAP staining was observed in a similar region to that of T2 
hyperintensity.  Long foot processes were visible and highly interconnecting at 20x 
magnification.  Outside of this region on the ipsilateral side, the callosum was no 
different from control. 
Electron Microscopy 
Parallel tissue samples taken from each brain used for GFAP immunohisto-
chemistry were prepared for electron microscopy.  Briefly, these were ipsilateral and 
contralateral corpus callosum samples taken from animals sacrificed 1 hour and 1 day 
post-infusion of 0.5 mM, 1.0 mM and 2.0 mM DCA.  
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Figure 4-6. Representative tissue stained for GFAP showing dose-dependence of the 
corpus callosum to 0.5 (C,D), 1.0 (E,F), and 2.0 (G,H) mM DCA infusion compared to 
contralateral (A,B) at 1 hour (A, C, E, G) and 1 day (B, D, F, H) post-infusion.  
Increased GFAP staining is present in (F), (G), and (H).  Images taken at 4x 
magnification.  
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Figure 4-7. Representative tissue stained for GFAP showing dose-dependence of the 
corpus callosum to 0.5 (C,D), 1.0 (E,F), and 2.0 (G,H) mM DCA infusion compared to 
contralateral (A,B) at 1 hour (A, C, E, G) and 1 day (B, D, F, H) post-infusion.  Large 
presence of cell bodies with few interconnections visible in (D).  Dark background 
staining with few astrocytic processes are seen in (F).  Prominent, interconnecting 
astrocytic processes in (G) and (H) produce a spider-web appearance.  Images taken at 
20x magnification.  
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Contralateral corpus callosum tissue samples taken from both 1 hour (Figure 4-8) 
and 1 day post-infusion (Figure 4-9) of all three DCA concentrations showed evidence of 
normal, healthy tissue ultrastructure.  Myelin closely surrounded neurons, and close 
apposition of perivascular astrocytic endfeet to blood vessels was observed.  No 
perivascular spaces were observed, nor was there other evidence of ECS expansion.  
Further, blood vessel morphology showed no abnormalities.  Intracellular organelles such 
as smooth endoplasmic reticulum (SER) were observed within the perivascular astrocytic 
endfeet without large electron-lucent areas indicative of swelling.  Glial somata did not 
show evidence of swelling, either.  Neural filaments were apparent and not compacted 
both at the node of Ranvier and within the intermodal segment.  Intra-axonally, 
mitochondria displayed normal cristae and no evidence of impaired axonal transport was 
observed.  Around the node, myelin paranodal loops were closely apposed to each other 
and to the paranodal axon segment.  Additionally, myelin ensheathment of the internodal 
segments of the axons was observed. 
Only two ultrastructural differences were observed in the ipsialateral corpus 
callosum following 0.5 mM DCA at 1 hour post-infusion (Figure 4-10) relative to 
contralateral.  Astrocytic endfeet surrounding blood vessels appeared swollen; 
intracellular areas with little presence of organelles comprised the swollen appearance.  
However, astrocytic endfeet tightly apposed blood vessels as seen contralaterally.  In 
addition, blood vessel morphology was normal relative to contralateral, except luminal 
pinocytic vesicles were observed inside blood vessels.  Myelin and neurons displayed no 
differences from   
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Figure 4-8.  Electron micrograph images of contralateral corpus callosum at 1 hour post-
infusion of DCA.  A demonstrates a blood vessel with the visible lumen (“L”).   Thick 
arrow indicates a neuron in cross section with normal myelin ensheathment and 
axoplasm.  B demonstrates a node of Ranvier ensheathed by tight, apposing paranodal 
loops (thick arrow).  Small arrow in A and B indicate artifactual space. 
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Figure 4-9.  Electron micrograph images of contralateral corpus callosum at 1 day post-
infusion of DCA.  A demonstrates a blood vessel.  Thin. arrow indicates a neuron in cross 
section with normal myelin ensheathment and axoplasm.  Thick arrow demonstrates 
normal intracellular components of an astrocytic endfoot.  B demonstrates a node of 
Ranvier ensheathed by tight, apposing paranodal loops (thin arrow).  
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contralateral at the node, paranode, or internode.  At 1 day post-infusion of 0.5 mM DCA 
(Figure 4-11), the ipsilateral corpus callosum displayed the same ultrastructural 
characteristics as that of 0.5 mM DCA infusion at 1 hour.  Perivascular astrocytic endfeet 
were swollen but tightly apposed to blood vessels, which were similar to contralateral.  
Myelin and neurons displayed no differences from contralateral, as well.  No pinocytic 
vesicles were observed. 
Ipsilaterally at 1 hour post-infusion of 1.0 mM DCA (Figure 4-12), ECS 
expansion was evident and perivascular spaces were observed, as well as swollen 
perivascular astrocytic endfeet.  Pinocytic vesicles appeared on the lumen of some blood 
vessels.  Proximal to the needle tract, intra-axonal electron-dense areas were observed 
inside of some neurons indicating impaired axonal transport, although others displayed 
features similar to contralateral.  These electron densities were observed in the internode 
and at the node, but no blebbing at the node was observed.  In addition, the myelin-
neuron interface was no different from contralateral.  Regions lateral to the needle tract 
but still within the area identified as hyperintense by MRI T2-weighted imaging 
displayed the ECS expansion and swollen perivascular astrocytic endfeet, but neurons 
were similar to those observed contralaterally.  Normal intracellular organelles and 
axoplasm, no blebbing at the nodes, and normal myelin and axon structural features were 
apparent throughout the axons. 
1 day following 1.0 mM DCA infusion (Figure 4-13), ipsilateral ultrastructural 
differences relative to contralateral were observed.  Evidence of ECS expansion was 
observed in some samples but not others, although swollen perivascular astrocytic   
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Figure 4-10.  Electron micrograph images of ipsilateral corpus callosum at 1 hour post-
infusion of 0.5 mM DCA.  A demonstrates a blood vessel.  Arrow indicates a pinocytic 
vesicle.   Asterisk (*) demonstrates swelling with a perivascular astrocytic end foot.  B 
demonstrates a normal node of Ranvier.  
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Figure 4-11.  Electron micrograph images of contralateral corpus callosum at 1 day post-
infusion of 0.5 mM DCA.  A demonstrates a blood vessel.  Asterisk (*) demonstrates 
swelling with a perivascular astrocytic end foot.  B shows a normal node of Ranvier.  
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endfeet apposed to blood vessels of normal morphology were observed.  Pinocytic 
vesicles were visible, as well.  Nodes displayed normal axoplasm and morphology.  
Internodes and paranodes displayed normal ensheathment by myelin as well as normal 
organelles, and no intra-axonal electron-dense areas were observed. 
When a concentration of 2.0 mM DCA was infused, multiple ultrastructural 
differences existed ipsilaterally relative to contralateral at 1 hour post-infusion (Figure 4-
14).  Tissue proximal to the needle tract was in poor condition after processing, but tissue 
in areas displaying heavy GFAP upregulation were able to be observed.  ECS expansion, 
perivascular spaces, and swelling of perivascular astrocytic endfeet were all observed.  
Pinocytic vesicles were observed on the luminal face of some blood vessels.  Examples 
of nodal blebbing were observed, although normal myelin ensheathment to the axon was 
observed.  No intra-axonal electron-dense bodies or were observed but some abnormal 
mitochondrial cristae were observed. 
Ipsilateral to infusion at 1 day following 2.0 mM DCA infusion (Figure 4-15), 
ECS expansion and perivascular spaces were observed.  Swollen perivascular astrocytic 
endfeet were also present, as were interendothelial vacuolizations within swollen 
endothelial cells.  Intra-axonal clustering of organelles and disruption of the cellular 
membrane was observed in some axons, although others displayed no difference from 
contralateral.  Further, some myelin degeneration was observed although myelin tightly 
apposed other axons. 
Following infusion of each concentration of DCA, no ultrastructural abnormalities 
were observed in glial somata at 1 hour or 1 day post-infusion, similar to control.  
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Figure 4-12.  Electron micrograph images of ipsilateral corpus callosum at 1 hour post-
infusion of 1.0 mM DCA.  A demonstrates a blood vessel.  Arrow indicates a normal 
neuron in cross section.  Perivascular space noted by “P.”  B demonstrates a normal node 
of Ranvier, but ECS expansion is evident (“E”).  
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Figure 4-13.  Electron micrograph images of ipsilateral corpus callosum at 1 day post-
infusion of 1.0 mM DCA.  A demonstrates a blood vessel.  Asterisk (*) demonstrates 
swelling with a perivascular astrocytic end foot.  B demonstrates a normal node of 
Ranvier.  
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Figure 4-14.  Electron micrograph images of ipsilateral corpus callosum at 1 hour post-
infusion of 2.0 mM DCA.  A demonstrates a blood vessel surrounded by ECS expansion 
(“E”).  Thick arrow indicates healthy neuron, whereas think arrow indicates a 
demyelinating axon.  B demonstrates a node of Ranvier with blebbing (arrow). 
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Figure 4-15.  Electron micrograph images of ipsilateral corpus callosum at 1 day post-
infusion of 2.0 mM DCA.  A demonstrates a swollen pericyte (arrow) surrounded by ECS 
expansion (“E”).  Thick arrow indicates a necrotic neuron with electron-dense axoplasm.  
B demonstrates a blood vessel and swollen astrocytic end foot (*).  
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T9 Glioma-Bearing Rats 
Consistent results were observed among all tumor-bearing rats, and as with 
stereotactic DCA infusions, the region of interest was the corpus callosum ipsilateral to 
tumor. 
On MRI (Figure 4-16), Gd-enhanced T1-weighted imaging (Figure 4-16, A) 
qualitatively showed tumor boundaries localized to the right striatum striatum, and T2-
weighted imaging (Figure 4-16 B) showed peritumoral hyperintensity surrounding the 
tumor mass and within the ipsilateral corpus callosum.  No T2 hyperintensity was 
observed in the contralateral corpus callosum.  Mass effect was observed on in both T1-
weighted and T2-weighted images. 
GFAP immunohistochemistry qualitatively demonstrated GFAP upregulation 
ipsilateral to the tumor in the corpus callosum at 4x and 20x magnification, as seen by 
dark color coloring and interconnecting astrocytic cell processes.  Contralateral 
hemispheres showed no evidence of GFAP upregulation.  Images of tissue stained for 
GFAP can be seen in Figure 4-17.  
EM analysis qualitatively demonstrated no ultrastructural abnormalities in the 
corpus callosum contralateral to the tumor (Figure 4-18, A).  Ipsilaterally (Figure F-18, 
B, C, D), however, ultrastructural differences in the corpus callosum relative to 
contralateral were observed.  ECS expansion was evident and some perivascular spaces 
were observed.  However, axons and myelin displayed normal ultrastructural 
morphology. 
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Figure 4-16.  Parallel MRI Gd-enhanced T1-weighted (A) and T2-weighted (B) images 
of coronal slices from a rat brain at 20 days post-implantation of T9 glioma.  Tumor 
boundary is visible in hypertensities visible in both both A and B, particularly in the 
bottom middle slice of each image set.  Top left and top middle slices in B demonstrate 
hyperintensities localized to the corpus callosum.  
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Figure 4-17. Photomicrographs of coronally-sectioned tissue stained for GFAP from 
animal implanted with T9 glioma.  Ipsilateral is seen in A (4x) and B (20x), and 
contralateral is seen in C (4x) and D (4x).  Contralateral corpus callosum displays similar 
qualitative staining profile as observed in the contralateral corpus callosum following 
DCA infusions.  Ipsilateral shows dark staining (A) and evident spider-web appearance in 
the cellular morphology (B).  
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Figure 4-18.  Electron micrograph images of contralateral (A) and ipsilateral (B, C, D) 
corpus callosum in animals implanted with T9 gliomas.   Thick arrows in A, C, and D 
demonstrate normal neuronal and myelin ultrastructure.  B and D demonstrate blood 
vessels (“L” indicates lumen).  Thin arrow in B demonstrates healthy endothelial cell and 
“E” indicates ECS expansion.  Large perivascular space (“P”) exists in D.  
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Chapter 5 
Discussion 
 
VEGF 
The literature documents VEGF as a potent cytokine capable of inducing vascular 
leakage followed by angiogenesis (Folkman et al. 1995).  Despite these findings, VEGF 
infusion did not produce noticeable extravasation of serum proteins in this study.  Serum 
protein extravasation was evaluated by visualization of EB in the infusion site following 
intravenous EB administration and transcardial perfusion.  EB binds irreversibly to serum 
proteins, and one would expect that protein extravasation across a compromised BBB 
would be visible when EB is bound.  The lack of visible blue staining of the parenchyma 
in any of the parameters tested suggests that stereotactic infusion of VEGF does not 
induce significant BBB breakdown. 
EB extravasation is a common method of evaluating BBB breakdown and 
albumin extravasation (Shukla 2006), but others have evaluated BBB breakdown 
following VEGF infusion using different techniques.  In one study (Dobrogowska et al. 
1998), albumin extravasation and BBB integrity were evaluated 10 minutes, 30 minutes 
and 24 hours following stereotactic infusion of 10 µL of 4µg/mL VEGF into the mouse 
cortex; these same evaluations were performed on untreated animals and at 10 and 30 
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minutes following stereotactic saline infusion.  Ultrastructural analysis by transmission 
electron microscopy (TEM) was performed and immunogold staining for albumin 
permitted its quantification using TEM.  The authors found small amounts of albumin in 
the subendothelial space and perivascular neuropil of all saline-infused animals, which 
was quantitatively similar to albumin present in untreated animals.  VEGF infusion 
caused an increase of albumin extravasation to the subendothelial space but not to the 
perivascular neuropil.  In addition, ultrastructural analysis of the endothelial cells showed 
small differences in their structure compared to saline and normal brain but no tight 
junction variability. 
The experiment performed by Dobrogowska et al. (1998) is similar to stereotactic 
infusions performed for this thesis of 20 µL of 1 and 5 µg/mL VEGF into the striatum, 
after which animals received EB and were sacrificed 1 hour post-infusion.  Due to the 
closeness of concentrations and time parameters, the larger volume of infusion, and the 
fact that EB binds albumin irreversibly (Shukla 2006), one would expect that albumin 
would extravasate and be visible by EB.  Because we did not observe EB extravasation in 
the area of infusion upon sectioning, this finding suggests that stereotactic infusion of 
VEGF did not produce significant BBB disruption and albumin extravasation, which 
contradicts the findings of Dobrogowska et al.  However, there may be a difference in 
sensitivity between gross visualization of EB and immunogold visualization of albumin 
at the ultrastructural level.  Dobrogowska et al. observed significant albumin 
extravasation in the subendothelial space but not in the perivascular neuropil 
(Dobrogowska et al. 1998).  If albumin localizes only to this specific area and does not 
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extend to the surrounding neuropil following VEGF infusion then EB staining localized 
to this small region might not be visible grossly.  This would suggest that immunogold 
labeling of albumin is a more sensitive technique for visualizing extravasated albumin 
than grossly viewing EB. 
Another interesting aspect of the paper is that the authors neither stated nor 
implied that saline and VEGF infusions induced edema nor did they show perivascular 
spaces at the ultrastructural level (Dobrogowska et al. 1998), which are seen in the 
albumin infusion model of edema (Ohata et al. 1990).  The authors showed some 
alterations of the endothelial cell morphology but no alteration of tight junctions 
(Dobrogowska et al 1998).  Although VEGF infusion by these authors caused albumin 
extravasation and altered endothelial cell morphology, the lack of morphological 
characteristics of edema could mean that the amount of serum protein extravasation was 
insufficient to cause edema.  Determination of water content or another evaluation of 
fluid extravasation for the infused tissue could show whether the BBB alteration and 
albumin extravasation was sufficient to produce edema. 
Some of our other VEGF experiments utilized micro-and mini-osmotic pumps to 
allow continuous infusion of 1 µg/mL VEGF into the rat cortex for 3 and 5 days, 
respectively.  Again, no EB extravasation was observed grossly in the infused region 
upon sectioning.  In a similar experiment, Croll et al. (2004) showed increased 
inflammatory response to VEGF infusion by micro-osmotic pump that increased over 7 
days.  Dose-dependent IgG and leukocyte extravasation, as well as altered vascular 
morphology were observed in the rat cortex infused for 1-7 days with 2.5, 5, 10 and 20 
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µg/mL VEGF relative to PBS using the same model micro-osmotic pumps as in our 
experiment.  Immunohistochemical stains for leukocytes, IgG, and endothelial cells were 
used to visualize them by light microscopy.  Additionally, Western blotting quantitatively 
revealed IgG and ICAM-1, an adhesion molecule necessary for diapedesis by leukocytes, 
upregulation. 
The lower two concentrations used by Croll et al. were within the same order of 
magnitude but larger nonetheless than those used in our experiment.  A dose-dependence 
was observed (Croll et al. 2004) and therefore the 1 µg/mL VEGF infusion used in our 
experiment would not be expected to induce the magnitude of effects seen by Croll et al.  
The authors noted modest leukocyte and IgG extravasation 1 day and robust 
extravasation on days 3-7 for all concentrations but with a dose-dependence on the 
intensity of staining at each time point.  Performance of this experiment with 1 µg/mL 
VEGF would tell either that this concentration was sufficient to induce leukocyte and/or 
IgG extravasation, or  that a minimum dose for extravasation exists between 1 and 2.5 
µg/mL VEGF.  If 1 µg/mL VEGF is sufficient to induce these effects as seen by the 
methods of Croll et al., then we could conclude that gross EB visualization is a less-
sensitive tool for evaluation of vascular leakage than immunostaining for IgG and 
leukocytes.  Further, if 1 µg/mL VEGF infusion is not sufficient to induce vascular 
leakage, then gross EB evaluation should be performed on the higher concentration 
parameters and compared to determine if this technique is as sensitive as 
immunohistochemistry for IgG and leukocytes. 
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The issue of specificity may also be a concern when comparing our methods to 
those of Croll et al. (2004).  EB binds with high affinity to albumin (Radius and 
Anderson 1980), and because albumin is the predominant protein in plasma (Vert and 
Domurado 2000), we measured predominantly albumin extravasation.  Other authors 
have measured both albumin extravasation by EB visualization with fluorescence 
microscopy or other techniques, and IgG extravasation by immunohistochemistry for a 
given experiment to evaluate vascular permeability (Shimamura et al. 2006; Chen et al. 
2008). 
VEGF is known for its role as a BBB permeability factor in the inflammatory 
response (Proescholdt et al. 1999), so VEGF-induced vascular leakage could show 
preference for components of the immune system.  Dobrogowska et al. (1998) showed 
that VEGF infusion permitted albumin extravasation but did not show evidence of 
edema, suggesting that the amount of albumin leakage subsequent to stereotactic VEGF 
infusion was insufficient to cause edema.  Repetition of this experiment to determine 
whether or not an immune response occurred would be useful, as Croll et al. similarly did 
not observe edema within 24 hours of exogenous VEGF introduction. In these 
experiments (Croll et al. 2004), the authors showed IgG and leukocyte extravasation with 
as little as 1 day of continuous infusion but morphological evidence of edema was 
evident only after 7 days of continuous infusion.  As mentioned above, repetition of the 
Croll et al. experiments could point to the presence or absence of a sensitivity difference 
between gross EB visualization and immunohistochemistry techniques, but they may also 
indicate a specificity preference for immune system components during VEGF-induced 
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vascular leakage.  Croll et al. even showed that ICAM-1 was upregulated, which 
specifically permits leukocytes to extravasate during diapedesis (Croll et al. 2004).  For 
repetition of these experiments, one would need to use techniques with similar sensitivity 
to measure IgG and albumin extravasation.  In addition, repetition of the Dobrogowska et 
al. (2004) experiments with staining for IgG compared to that of albumin would provide 
further information on the question of preferential BBB permeability in VEGF-induced 
vascular leakage. 
The purpose of this study was to determine if VEGF could be used as a model of 
pure vasogenic edema in the rat brain.  We first set out to decide if VEGF could induce 
BBB breakdown and serum protein extravasation before investigation of water content.  
No evidence of serum protein extravasation using gross EB visualization was observed 
after multiple parameters of VEGF infusion followed by intravenous EB administration, 
and therefore no analysis of water content was performed.   Because similar experiments 
did show evidence of serum protein extravasation using different evaluation techniques, 
further experiments as described above should be performed to compare the sensitivities 
of these techniques, and to investigate the specificity of vascular leakage before 
attempting experiments to evaluate edema. 
Deoxycholic Acid 
Contralateral Control 
All brain infusions were performed in the right cerebral hemisphere of the rat 
brains.  The left cerebral hemisphere served as a control because no effect was expected 
or observed contralateral to the infusion for the same brain region.  For visualization of 
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EB staining, no EB was present in the contralateral symmetrical region so internal 
controls were used for comparison. 
On MRI, observed brain water content of the contralateral corpus callosum was 
consistent for each experimental parameter, and was similar to human brain as seen by 
Fatouros and Marmarou (1999); human corpus callosum is approximately 68% water.  
These authors attributed the presence of myelin, a lipid, in white matter to the smaller T1 
signals relative to greater T1 signals observed in gray matter, which had water content of 
77.1% and 80.3% in representative regions (lentiform and caudate nuclei, respectively).  
This suggests that the contralateral corpus callosum is an adequate control for comparison 
with the ipsilateral corpus callosum for MRI experiments. 
Two animals received stereotactic saline infusions into the corpus callosum, and 
were given EB and sacrificed 1 hour post-infusion.  No EB extravasation occurred 
ipsilateral or contralateral to infusion.  In addition, GFAP staining ipsilateral to infusion 
for these animals showed no difference from contralateral following saline infusion, and 
both sides displayed no difference from each contralateral corpus callosum from DCA-
infused animals.  This suggests that the contralateral corpus callosum is an appropriate 
control for comparison with the ipsilateral corpus callosum in EB and GFAP 
experiments. 
On the EM, consistency between all contralateral corpus callosum samples from 
treated animals at both 1 hour and 1 day was observed.   Morphologic observations of the 
contralateral samples were consistent with normal ultrastructural characteristics such as 
tight ensheathment of axons by myelin, tightly-apposed paranodal loops (Dupree et al. 
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2005), apposition of perivascular astrocytic end feet to pericytes and endothelial cells 
(Ohata et al. 1990), lack of glial and axonal swelling (Singleton et al. 2002), and lack of 
NF compaction (Gallyas et al. 2006).  Further, glial somata all displayed normal and 
consistent ultrastructure for both time points.  These ultrastructural observations 
permitted the use of internal controls for EM experiments. 
Evaluation of Edema 
As described in the introduction, exogenous DCA application to the brain has 
been shown to disrupt the BBB (Greenwood et al. 1991), allowing serum albumin 
extravasation and the formation of vasogenic edema (Seiffert et al. 2004).  However, 
these studies did not thoroughly examine the purity of vasogenic edema.  In experiments 
by Greenwood et al., no examination of cellular swelling was performed following 
intracarotid DCA perfusion (Greenwood et al. 1991).  Seiffert et al. showed EB 
extravasation, increased T1 and T2 signal intensities on MRI, and GFAP increase in 
response to cortical perfusion with DCA (Seiffert et al. 2004).  ADC measurements 
would tell whether the increased tissue water content occurred predominantly in the 
intracellular or extracellular compartments of the tissue.  In fact, the GFAP increase, as a 
marker for astrocytic reactivity, suggests the presence of cellular edema, although this 
increase did not occur immediately, and therefore investigation into the exact location of 
the excess fluid would permit definition of the edema as purely vasogenic or cytotoxic, or 
a heterogeneous mixture of each. 
Our studies utilized multiple techniques to provide specific information regarding 
tissue fluid components, tissue water content, location of excess tissue fluid, and 
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ultrastructural analysis following infusion of 0.5 mM, 1.0 mM and 2.0 mM DCA after 1 
hour and 1 day.  From the results of these individual techniques, an assessment of edema 
formation and edema type was made for each of these 6 parameters.  EB staining 
suggested that extravasated serum proteins and fluid contributed to any observed edema.  
Edema was defined as a significant increase in water content on MRI in the region of 
hyperintensity; if this was observed, a significant ADC increase was then required to 
show the predominance of vasogenic edema.  ADC increase indicates a predominant 
increase in extracellular fluid, but this signal may represent average water diffusivity 
throughout the tissue.  Therefore further examination of the tissue is necessary to 
determine if there is intracellular swelling in addition to interstitial fluid accumulation 
when water content and ADC are significantly increased.  GFAP upregulation indicated 
astrocytic cell reaction, along with indications of both interstitial fluid accumulation and 
cellular swelling that were observed by EM. 
0.5 mM DCA 
It has previously been shown that DCA concentrations below 1.0 mM did not 
disrupt BBB function when perfused through the carotid artery in exsanguinated rats, as 
evidenced by no observed extravasation of intravenous [
14
C]mannitol (Greenwood et al. 
1991).  Greenwood et al. also demonstrated in this study that the concentration of 
[
14
C]mannitol did not contribute to BBB disruption.  The study further showed that DCA 
concentrations below 1.5 mM did not cause “lytic action” on RBCs (Greenwood et al. 
1991), which was consistent with our ultrastructural observations on the effects of a 
similar range of concentrations of DCA infused intraparenchymally.  In our study, no EB 
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staining was observed following 0.5 mM DCA infusion both at 1 hour and 1 day.  This 
result suggested that no functional disruption of the BBB occurred, which is consistent 
with the aforementioned study (Greenwood et al. 1991).  As a whole, our results taken in 
the context of the other studies cited suggest that any potential increase in tissue water 
content following 0.5 mM DCA consists solely of the infusate fluid. 
At 1 hour, ipsilateral T2 hyperintensity was observed in the corpus callosum, but 
average water content increased without attaining significance, which demonstrated that 
significant edema was not present.  Interestingly, the significant increase in ADC showed 
an increase in extracellular fluid, although no perivascular spaces or other evidence of 
ECS expansion was observed ultrastructurally.  In fact, the observation of swollen 
astrocytic end feet without evidence of ECS expansion suggested the contrary - that 
cellular fluid accumulation occurred.  However, GFAP upregulation was not observed, 
suggesting that the presence of infusate fluid did not cause the astrocytes to become 
reactive.  Therefore this ultrastructural observation of cellular fluid accumulation 
indicates that the astrocytes made an insignificant contribution to fluid clearance, as 
further supported by the observation that glial somata did not appear swollen.  This 
would be expected based on documented observations that astrocytes uptake extravasated 
proteins in vasogenic edema, thereby lowering the extracellular oncotic pressure 
(Stummer 2007).  The insignificance of the observed water content increase does 
correlate with both the lack of GFAP upregulation and the lack of evidence for 
ultrastructural ECS expansion.  In addition, no ipsilateral GFAP upregulation was 
observed at 1 day despite swelling of perivascular astrocytic end feet.  No difference 
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between contralateral and ipsilateral was observed by MRI, and no ultrastructural 
observations of ECS expansion, perivascular spaces, glial somata, or neuronal pathology 
were observed, as well.   
Taken together, these results suggest that the observed swellings due to 0.5 mM 
DCA infusion made an insignificant contribution to overall distribution of infusate.  
Further, the results of this experiment suggest that the infusion of 0.5 mM DCA does not 
produce edema at 1 hour and 1 day, and is therefore inappropriate for studies of 
vasogenic edema.  However, replication of this experiment may permit water content 
increase to attain significance if additional trials produce similar T1 values on MRI to 
those already documented in this study, and suggest the presence of vasogenic edema due 
solely to infusate fluid at 1 hour post-infusion. 
1.0 mM DCA 
Consistent with the findings of Greenwood et al. (1991) and Seiffert et al. (2004), 
we observed EB staining in the ipsilateral corpus callosum at 1 hour post-infusion of 1.0 
mM DCA.  In addition, MRI revealed T2 hyperintensity and significant increase in water 
content consistent with the results of Seiffert et al. (2004).  We therefore determined that 
this infusion parameter induced edema by disruption of the BBB and extravasation of 
serum albumin, and the significant ADC increase suggested a predominance of vasogenic 
edema.  As mentioned above, the infusate fluid likely contributes to the total edema, 
which would suggest that the total edema volume in this parameter is a combination of 
infusate fluid and extravasated serum fluid. 
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At 1 hour, no GFAP upregulation was observed, but we did see swelling of 
perivascular astrocytic end feet at the ultrastructural level.  However, no glial somata 
swelling was observed.  The lack of GFAP upregulation suggests that the end foot 
swelling did not contribute significantly to the observed edema.  Further, perivascular 
spaces and ECS expansion were apparent, and no other ultrastructural evidence of 
cellular swelling was observed.  These GFAP and ultrastructural findings are consistent 
with the significant ADC increase, and the results as a whole suggest the existence of 
pure vasogenic edema for this parameter.  Our finding is consistent with the findings of 
Greenwood et al. (1991), who endorsed 1.0 mM DCA as an optimal concentration for 
BBB disruption that permits albumin extravasation without necrotic tissue damage. 
Our findings show that this edematous state is dynamic in a time-dependent 
manner.  1 day post-infusion of 1.0 mM DCA we observed no functional BBB disruption, 
and no significant difference in both water content and ADC between ipsilateral and 
contralateral, although both averages were greater than contralateral.  Some tissue 
samples showed evidence of ECS expansion but could be attributed to artifact of tissue 
process, as no perivascular spaces were observed.  We therefore concluded that the DCA-
induced BBB disruption is temporary, and that the brain had cleared the edema fluid seen 
at 1 hour post-infusion, making the 1-day time point inappropriate for study of vasogenic 
edema. 
Ultrastructurally, no abnormalities were observed in myelin, axons, or glial 
somata, suggesting that the edema produced by this treatment did not produce permanent 
tissue pathology.  However, GFAP upregulation and swollen perivascular astrocytic end 
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feet were observed, indicating cellular swelling.  Astrocytic function of extravasated 
proteins may be the cause of this observed astrocyte reaction.  Because MRI in no way 
indicated cellular swelling and other ultrastructural characteristics were normal, the 
observed astrocytic reaction is likely due to a small amount of protein clearance still 
persisting at this time, which is consistent with previous findings that several days are 
required for removal of albumin from the ECS (Ohata et al. 1990; Fatouros et al. 1990).  .   
These other studies have shown that clearance of proteinaceous fluid from the 
brain takes 8 days (Ohata et al. 1990; Fatouros et al. 1990).  The major clearance pathway 
is currently thought to be through perivascular spaces (Ohata et al. 1990), but astrocytes 
were previously thought to clear the majority of fluid (Klatzo 1987).  The combination of 
multiple mechanisms in edema clearance is well-supported nonetheless (Klatzo 1987) 
(Ohata et al. 1990).  At 1 day post-infusion of 1.0 mM DCA, our results showed neither 
significant edema nor perivascular spaces, suggesting that a large amount of fluid had 
cleared through the perivascular spaces as observed by Ohata et al. (1990).  Swollen 
astrocytes indicated that the astrocytic mechanism of clearance was also apparent, 
although these did not show prominence until 1 day.  Seiffert et al. (2004) also observed 
GFAP increase following their 1.0 mM DCA perfusion over the cortex.  In a later study 
by this same group, they showed that astrocytes take up extravasated serum albumin 
through the TGF-β receptor within 6-8 hours following 2.0 mM DCA perfusion over the 
cortex (Ivens et al. 2007), and interstitial water would presumably follow the albumin 
(Klatzo 1987).  This time course of albumin uptake by astrocytes explains why 
significant astrocytic swelling was not observed at 1 hour.  Due to our observations in the 
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scope of work, we suggest that the fluid clearance following 1.0 mM DCA is attributable 
to perivascular pathways and to astrocytic uptake, with the former predominating and 
removing the majority of edematous fluid before the latter. 
2.0 mM DCA, 1 Hour Post-infusion 
Infusion of 2.0 mM DCA produced an ipsilateral necrotic lesion in the corpus 
callosum proximal to the needle tip, which was surrounded by a region of mixed 
vasogenic and cytotoxic edema, with a predominance of the former.  All MRI 
measurements (T2 signal, water content, and ADC) suggested a predominance of 
vasogenic edema throughout the region of interest at both time points.  However, 
astrocytic swelling was observed ultrastructurally, suggesting that the edema was not 
purely vasogenic.  Observed astrocyte morphology was consistent with documented 
morphology of reactive astrocytes (Gomide et al. 2005), particularly through our 
observation of interconnecting astrocytic processes.  Interestingly we did not observe 
ultrastructural abnormalities in glial somata at both time points, but these somata were 
sparse relative to axons and blood vessels and perhaps further investigation could show 
evidence of pathology. 
Tissue necrosis due to 2.0 mM DCA is consistent with findings of the 
aforementioned Greenwood et al. (1999) paper, in which the authors showed cell 
membrane lysis and pathological cerebral blood vasculature following intracarotid 
perfusion of DCA at concentrations of 1.5 mM and higher in exsanguinated rats.  
Additionally, Ivens et al. (2007) showed BBB disruption by EB extravasation with 2.0 
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mM DCA perfusion over the rat cortex, which we similarly observed with 
intraparenchymal infusion. 
These findings are consistent with our previous results showing BBB disruption 
and vasogenic edema formation following a DCA infusion with a lower concentration 
(1.0 mM).  Together, they suggest a dose-dependence of DCA on BBB disruption, edema 
formation and cytotoxicity following direct intraparenchymal delivery.  In addition, we 
suggest that infusion of 2.0 mM DCA does not produce pure vasogenic edema and is 
therefore not optimal for study of this brain state. 
Tumor-Bearing Rats 
The qualitatively-assessed characteristics of the T9 glioma-bearing rats was 
consistent with known features of peritumoral edema in the corpus callosum.  
Peritumoral edema typically resides in the white matter (Raslan and Bhardwaj 2007), 
which is where we observed our findings.  Mass effect, ipsilateral T2-weighted 
hyperintensity, and ipsilateral GFAP upregulation in combination with ultrastructural 
observations (e.g. perivascular spaces and expanded ECS ipsilaterally) suggested the 
presence of ipsilateral edema, predominantly of the vasogenic type.  To further support 
this claim, no evidence of necrosis was observed in throughout the tissue. 
The upregulated GFAP suggests astrocytic reaction to the proteinaceous fluid 
extravasation.  As mentioned before, however, astrocytic reaction to proteinaceous fluid 
extravasation specifically involves uptake of the extravasated albumin without the fluid 
in an effort to lower extracellular oncotic pressure (Stummer 2007).  Together, our 
observed results in combination with the documented astrocytic response to peritumoral 
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edema suggest a purely vasogenic edema state in the ipsilateral corpus callosum due to 
the brain tumor.  Still, measurement of water content would have quantitatively given 
evidence for significant edema, and ADC measurement would have similarly provided 
quantitative evidence suggesting a predominance of vasogenic edema.  
Further, the effect on the ipsilateral corpus callosum observed at 1 hour following 
1.0 mM DCA infusion parallel this peritumoral vasogenic edema state, with the exception 
that GFAP was not upregulated significantly following DCA infusion at this time.  
However, GFAP increased at the 1 day time point from this same treatment.  As 
suggested above, the astrocytic response to extravasated albumin following this treatment 
takes longer than 1 hour but less than 24 hours to occur.  In the tumor, several days of 
gadolinium enhancement around the tumor margin demonstrate that the BBB was 
compromised for this time and presumably serum albumin would have extravasated.  
This would have permitted enough time for the astrocytic response (upregulated GFAP) 
to occur in the tumor, which is consistent the time-dependent GFAP increase observed 
following 1.0 mM DCA infusion.  It is important to remember that the observed BBB 
disruption following a single DCA infusion was transient, whereas tumors continuously 
maintain a disrupted BBB (Groothuis 2000).  This is consistent with our observation of 
no edema at 1 day post-infusion of 1.0 mM DCA, despite the observed edema at 1 hour 
post-infusion.   
 
Conclusion 
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The purpose of these studies was to develop a model of pure vasogenic edema.  
Preliminary experiments with several parameters of VEGF infusion did not indicate that 
this technique would produce the desired result.  Alternatively, DCA infusion 
experiments displayed a dose-dependence and time-dependence on the formation of 
edema.  Taken as a whole, we observed that infusion into the corpus callosum of 9 µL of 
1.0 mM DCA over 45 minutes produces pure vasogenic edema 1 hour post-infusion.  
Further, we suggest that the tumor-bearing rats exhibited peritumoral edema that was 
purely vasogenic.  Therefore, we suggest that this specific infusion parameter provides an 
optimal model for the study of vasogenic edema, particularly as it pertains to the 
vasogenic edema in the white matter surrounding brain tumors. 
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